MOLECULE,ROUTE,TECHNICAL_SPECIFICATIONS,ATC_CODE
Abacavir,Oral:,300 mg (as Sulfate) Tablet ,J05AF06
Abiraterone,Oral:,250 mg (as Acetate) Tablet ,L02BX03 
Acetated Ringer's Solution,Inj.:,"in 500 mL Bottle/Bag (IV Infusion)
Composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 3 mmol/L
Cl- = 109 mmol/L ",B05BB01
Acetated Ringer's Solution,Inj.:,"in 1 L Bottle/Bag (IV Infusion)
Composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 3 mmol/L
Cl- = 109 mmol/L ",B05BB01
Acetazolamide,Oral:,250 mg Tablet ,S01EC01
Acetylcysteine,Oral:,600 mg Effervescent tablet ,R05CB01
Acetylcysteine,Oral:,100 mg Sachet ,R05CB01
Acetylcysteine,Oral:,200 mg Sachet ,R05CB01
Acetylcysteine,Oral:,100 mg/5 mL Granules for suspension in 150 mL ,R05CB01
Acetylcysteine,Inj.:,200 mg/mL in 10 mL Ampul (IV Infusion) ,R05CB01
Acetylcysteine,Inj.:,200 mg/mL in 25 mL Bottle (IV Infusion) ,R05CB01
Acetylcysteine,Inhalation:,100 mg/mL Solution for inhalation in 3 mL Ampule ,R05CB01
Aciclovir,Oral:,200 mg Tablet *Primary Health Care,J05AB01
Aciclovir,Oral:,400 mg Tablet *Primary Health Care,J05AB01
Aciclovir,Oral:,800 mg Tablet *Primary Health Care,J05AB01
Aciclovir,Oral:,200 mg/5 mL Suspension in 60 mL *Primary Health Care,J05AB01
Aciclovir,Oral:,200 mg/5 mL Suspension in 120 mL *Primary Health Care,J05AB01
Aciclovir,Inj.:,25 mg/mL in 10 mL Vial (IV infusion) ,J05AB01
Activated Charcoal,Oral:,"Powder USP Grade, given as slurry *Primary Health Care",A07BA01
Adenosine,Inj.:,3 mg/mL in 2 mL Vial (IV) ,C01EB10
Albendazole,Oral:,400 mg Chewable tablet *Primary Health Care,P02CA03
Albendazole,Oral:,200 mg/5 mL Suspension in 10 mL *Primary Health Care,P02CA03
Albendazole,Oral:,200 mg/5 mL Suspension in 60 mL *Primary Health Care,P02CA03
"Albumin, Human",Inj.:,"20% in 50 mL Bottle (IV, IV infusion) ",B05AA01
"Albumin, Human",Inj.:,"20% in 100 mL Bottle (IV, IV infusion) ",B05AA01
"Albumin, Human",Inj.:,"25% in 50 mL Bottle (IV, IV infusion) ",B05AA01
"Albumin, Human",Inj.:,"25% in 100 mL Bottle (IV, IV infusion) ",B05AA01
"Albumin, Human",Inj.:,"25% in 50 mL Plastic bag (IV, IV infusion) ",B05AA01
"Alcohol, Ethyl",Oral:,95% USP grade ,V03AZ01
"Alcohol, Ethyl",Inj.:,Absolute in 1 mL Ampul (IV) ,V03AZ01
"Alcohol, Ethyl",Topical:,70% Solution *Primary Health Care,V03AZ01
Alendronate,Oral:,10 mg (as Sodium) Tablet ,M05BB03
Alendronate,Oral:,70 mg (as Sodium) Tablet ,M05BB03
Alendronate + Cholecalciferol/Vitamin D3,Oral:,70 mg (as Sodium) + 5600 IU Tablet ,M05BB03
Alfuzosin,Oral:,10 mg (as Hydrochloride) Tablet ,G04CA01
All-in-one Admixtures,,"Solution in 400-2500 mL composed of:
Concentration = variable
Protein = 3-6 g/100 mL
Carbohydrates = 6-15 g/100 mL
Lipid = 2-5 g/100 mL
Calories = variable
Electrolytes = variable ",B05BA10
Allopurinol,Oral:,100 mg Tablet ,M04AA01
Allopurinol,Oral:,300 mg Tablet ,M04AA01
Alprazolam,Oral:,250 mcg Tablet ,N05BA12
Alprazolam,Oral:,500 mcg Tablet ,N05BA12
Alprazolam,Oral:,1 mg Tablet ,N05BA12
Alteplase (Human Recombinant Tissue Type Plasminogen Activator),Inj.:,50 mg Powder (IV infusion) ,B01AD02
Aluminum + Magnesium,Oral:,"225 mg (as Hydroxide) + 200 mg (as Hydroxide) per 5 mL, Suspension in 60 mL ",A02AB10
Aluminum + Magnesium,Oral:,"225 mg (as Hydroxide) + 200 mg (as Hydroxide) per 5 mL, Suspension in 120 mL *Primary Health Care",A02AB10
Aluminum + Magnesium,Oral:,200 mg (as Hydroxide) + 100 mg (as Hydroxide) Tablet ,A02AB10
Amikacin,Inj.:,"50 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"100 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"125 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"250 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"100 mg (as Sulfate) Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"250 mg (as Sulfate) Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"500 mg (as Sulfate) Vial (IM, IV) ",J01GB06
Amikacin,Inj.:,"1 g (as Sulfate) Vial (IM, IV) ",J01GB06
Amino acid + Carbohydrate + Multivitamins + Electrolytes,Inj.:,Solution for IV injection/infusion in 1000 mL Infusion Set ,B05BA
Amino acid + Glucose + Electrolytes + Vitamin B1,Inj.:,Solution for peripheral venous infusion in 500 mL ,B05BA01
Amino acid + Glucose + Electrolytes + Vitamin B1,Inj.:,Solution for peripheral venous infusion in 1000 mL ,B05BA01
Amino acid solutions for Hepatic Failure,Inj.:,"Solution in 500 mL composed of:
Concentration = 5-10%
Protein = 35-50 g rich in branched-chain amino acids
Calories = 50-200
Electrolytes = variable ",V06DE
Amino acid solutions for Immunonutrition/Immunoenhancement,Inj.:,"Solution in 50 mL composed of:
Protein = 20g; L-alanyl-L-glutamine
Calories = 70-90
Electrolytes = none ",V06DE
Amino acid solutions for Immunonutrition/Immunoenhancement,Inj.:,"Solution in 100 mL composed of:
Protein = 20g; L-alanyl-L-glutamine
Calories = 70-90
Electrolytes = none ",V06DE
Amino acid solutions for Infants,Inj.:,"Solution in 100 mL composed of:
Concentration = 5-10%
Protein = 5-10g including taurine
Calories = 20-40 kcal
Electrolytes = none ",V06DE
Amino acid solutions for Renal Condition,Inj.:,"Solution 250-500 mL composed of:
Concentration = 3.5-7%
Protein = 17.5-35 g rich in essential amino acid
Calories = 50-200 kcal ",V06DE
"Amino acids, crystalline standard",Inj.:,3.5% in 500 mL Bottle (IV infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,5% in 100 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,5% in 250 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,5% in 500 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,6% in 100 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,6% in 250 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,7% in 100 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,7% in 500 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,7% in 1 L Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,8.5% in 100 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,8.5% in 500 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,8.5% in 1 L Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,10% in 100 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,10% in 500 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,10% in 1 L Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,11.4% in 100 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,11.4% in 500 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,11.4% in 1 L Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,8% (as Branched chain) in 500 mL Bottle (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,9.12% in 20 mL Ampul (IV Infusion) ,B05BA01
"Amino acids, crystalline standard",Inj.:,9.12% in 200 mL Bottle (IV Infusion) ,B05BA01
Aminophylline/Theophylline ethylenediamine,Inj.:,25 mg/mL in 10 mL Ampul (IV) ,R03DA05
Amiodarone,Oral:,200 mg (as Hydrochloride) Tablet ,C01BD01
Amiodarone,Inj.:,50 mg/mL (as Hydrochloride) in 3 mL Ampul (IV) ,C01BD01
Amlodipine,Oral:,5 mg (as Besilate/Camsylate) Tablet *Primary Health Care,C08CA01
Amlodipine,Oral:,10 mg (as Besilate/Camsylate) Tablet *Primary Health Care,C08CA01
Amoxicillin,Oral:,250 mg (as Trihydrate) Capsule *Primary Health Care,J01CA04
Amoxicillin,Oral:,500 mg (as Trihydrate) Capsule *Primary Health Care,J01CA04
Amoxicillin,Oral:,100 mg/mL (as Trihydrate) Granules/powder for drops in 15 mL *Primary Health Care,J01CA04
Amoxicillin,Oral:,250 mg/5 mL (as Trihydrate) Granules/powder for suspension in 60 mL *Primary Health Care,J01CA04
Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,500 mg (as Trihydrate) + 125 mg (as Potassium clavulanate) Tablet *Primary Health Care,J01CR02
Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,875 mg (as Trihydrate) + 125 mg (as Potassium clavulanate) Tablet *Primary Health Care,J01CR02
Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,"200 mg (as Trihydrate) + 28.5 mg (as Potassium clavulanate) per 5 mL, Granules/powder for suspension in 70 mL *Primary Health Care",J01CR02
Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,"400 mg (as Trihydrate) + 57 mg (as Potassium clavulanate) per 5 mL, Granules/powder for suspension in 70 mL *Primary Health Care",J01CR02
Amoxicillin + Clavulanic acid (Co-amoxiclav),Oral:,"600 mg (as Trihydrate) + 42.9 mg (as Potassium clavulanate) per 5 mL, Granules/powder for suspension *Primary Health Care",J01CR02
Amphotericin B *Reserve antimicrobial,Inj.:,"50 mg (as Cholesteryl complex, colloidal dispersion) Vial (Lipid complex) ",A07AA07 
Amphotericin B *Reserve antimicrobial,Inj.:,"100 mg (as Cholesteryl complex, colloidal dispersion) Vial (Lipid complex) ",A07AA07 
Amphotericin B *Reserve antimicrobial,Inj.:,50 mg Vial (Non-lipid complex) ,A07AA07 
Ampicillin,Inj.:,"250 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CA01
Ampicillin,Inj.:,"500 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CA01
Ampicillin,Inj.:,"1 g (as Sodium) Vial (IM, IV) *Primary Health Care",J01CA01
Ampicillin + Sulbactam,Inj.:,"500 mg (as Sodium) + 250 mg Vial (IM, IV) ",J01CR01
Ampicillin + Sulbactam,Inj.:,"1000 mg (as Sodium) + 500 mg Vial (IM, IV) ",J01CR01
Ampicillin + Sulbactam,Inj.:,"2000 mg (as Sodium) + 1000 mg Vial (IM, IV) ",J01CR01
Anastrozole,Oral:,1 mg Film-coated tablet ,L02BG03
Anti-D immunoglobulin (Human anti-D immunoglobulin),Inj.:,200 mcg/mL in 1.5 mL Ampul (IM) ,J06BB01
Antilymphocyte Immunoglobulin (ALG),Inj.:,100 mg/5 mL Vial (IV) (Equine) ,"L04AA03
"
Anti-rabies serum,Inj.:,200 IU/mL in 5 mL Vial (IM) (Equine) *Primary Health Care,J06BB05
Anti-rabies serum,Inj.:,400 IU/mL in 5 mL Vial (IM) (Equine) *Primary Health Care,J06BB05
Anti-tetanus serum,Inj.:,4000 IU/mL in 2.5 mL Vial (IM) (Equine) *Primary Health Care,J06AA02
Anti-tetanus serum,Inj.:,1500 IU/0.7 mL Solution for injection Ampul/Vial (IM) (Equine) *Primary Health Care,J06AA02
Anti-tetanus serum,Inj.:,1500 IU/mL in 1 mL Ampul/Vial (IM) (Equine) *Primary Health Care,J06AA02
Anti-tetanus serum,Inj.:,1500 IU/mL in 1.5 mL Ampul/Vial (IM) (Equine) *Primary Health Care,J06AA02
Antithymocyte Immunoglobulin (ATG),Inj.:,25 mg/5 mL Vial (IV) (Rabbit) ,L04AA04
Apixaban,Oral:,2.5 mg Film-coated tablet ,B01AF02 
Apixaban,Oral:,5 mg Film-coated tablet ,B01AF02 
Aripriprazole,Oral:,10 mg Tablet ,N05AX12
Aripriprazole,Oral:,15 mg Tablet ,N05AX12
Aripriprazole,Oral:,20 mg Tablet ,N05AX12
Aripriprazole,Oral:,30 mg Tablet ,N05AX12
Aripriprazole,Oral:,10 mg Orally disintegrating tablet (ODT) ,N05AX12
Aripriprazole,Oral:,15 mg Orally disintegrating tablet (ODT) ,N05AX12
Aripriprazole,Inj.:,300 mg (200 mg/mL) Lyophilized powder for extended-release suspension for injection Pre-filled dual chamber syringe ,N05AX12
Aripriprazole,Inj.:,400 mg (200 mg/mL) Lyophilized powder for extended-release suspension for injection Pre-filled dual chamber syringe ,N05AX12
Artemether + Lumefantrin,Oral:,20 mg + 120 mg Tablet *Primary Health Care,P01BF01
Artesunate,Inj.:,60 mg Vial ,P01BE03
Artesunate,Rectal:,50 mg Suppository ,P01BE03
Ascorbic acid (Vitamin C),Oral:,100 mg Tablet *Primary Health Care,A11GA01
Ascorbic acid (Vitamin C),Oral:,500 mg Tablet *Primary Health Care,A11GA01
Ascorbic acid (Vitamin C),Oral:,100 mg/5 mL Syrup in 60 mL *Primary Health Care,A11GA01
Ascorbic acid (Vitamin C),Oral:,100 mg/5 mL Syrup in 120 mL *Primary Health Care,A11GA01
Ascorbic acid (Vitamin C),Oral:,100 mg/mL Syrup in 15 mL *Primary Health Care,A11GA01
Ascorbic acid (Vitamin C),Oral:,100 mg/mL Syrup in 30 mL *Primary Health Care,A11GA01
Ascorbic acid (Vitamin C),Inj.:,250 mg/mL in 2 mL Ampul (IV) ,A11GA01
Asparaginase,Inj.:,"10,000 IU Lyophilized powder Vial (IV) ",L01XX02
Aspirin,Oral:,80 mg Tablet *Primary Health Care,B01AC06
Aspirin,Oral:,100 mg Tablet *Primary Health Care,B01AC06
Aspirin,Oral:,300 mg Tablet ,B01AC06
Aspirin,Oral:,325 mg Tablet ,B01AC06
Atenolol,Oral:,50 mg Tablet *Primary Health Care,C07AB03
Atenolol,Oral:,100 mg Tablet *Primary Health Care,C07AB03
Atorvastatin,Oral:,10 mg (as Calcium) Tablet *Primary Health Care,C10AA05
Atorvastatin,Oral:,20 mg (as Calcium) Tablet *Primary Health Care,C10AA05
Atorvastatin,Oral:,40 mg (as Calcium) Tablet *Primary Health Care,C10AA05
Atorvastatin,Oral:,80 mg (as Calcium) Tablet *Primary Health Care,C10AA05
Atracurium,Inj.:,10 mg/mL (as Besilate) in 2.5 mL Ampul (IV) ,M03AC04
Atracurium,Inj.:,10 mg/mL (as Besilate) in 5 mL Ampul (IV) ,M03AC05
Atropine,Oral:,600 mcg (equiv. to 500 mcg atropine) (as Sulfate) Tablet *Primary Health Care,S01FA01
Atropine,Inj.:,"500 mcg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) ",S01FA01
Atropine,Inj.:,"600 mcg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) ",S01FA01
Atropine,Inj.:,"1 mg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) *Primary Health Care",S01FA01
Atropine,Ophthalmic:,1% (as Sulfate) Solution in 5 mL (Ophthalmic drops) ,S01FA01
Atropine,Ophthalmic:,1% (as Sulfate) Solution in 10 mL (Ophthalmic drops) ,S01FA01
Azathioprine,Oral:,50 mg Tablet ,L04AX01
Azithromycin,Oral:,250 mg (as Base*/dihydrate) Capsule *Primary Health Care,J01FA10
Azithromycin,Oral:,250 mg (as Base*/dihydrate/monohydrate) Tablet *Primary Health Care,J01FA10
Azithromycin,Oral:,500 mg (as Base*/dihydrate/monohydrate) Tablet *Primary Health Care,J01FA10
Azithromycin,Oral:,200 mg/5 mL (as Base*/dihydrate/monohydrate) Powder for suspension in 15 mL *Primary Health Care,J01FA10
Azithromycin,Oral:,200 mg/5 mL (as Base*/dihydrate/monohydrate) Powder for suspension in 60 mL *Primary Health Care,J01FA10
Azithromycin,Inj.:,500 mg (as Base*/dihydrate) Powder Vial (IV infusion) ,J01FA10
Aztreonam *Reserve antimicrobial,Inj.:,1 g Powder for injection ,J01DF01
Bacitracin + Neomycin + Polymixin B,Topical:,"200 IU + 3 mg (as Sulfate) + 4000 IU (as Sulfate) per g, Ointment in 10 g Tube ",D06AX05
Baclofen,Oral:,10 mg Tablet ,M03BX01
Balanced Multiple Maintenance Solution + Dextrose,Inj.:,"in 250 mL Bottle/Bag (IV infusion) (Infants) with 5% Dextrose composed of:
Dextrose = 50 g/L
Na+ = 25-30 mmol/L
K+ = 20-25 mmol/L
Mg++ = 1.35-1.65 mmol/L
Cl- = 22 mmol/L
Acetate = 23 mmol/L  *Primary Health Care",B05BB02
Balanced Multiple Maintenance Solution + Dextrose,Inj.:,"in 500 mL Bottle/Bag (IV infusion) (Infants) with 5% Dextrose composed of:
Dextrose = 50 g/L
Na+ = 25-30 mmol/L
K+ = 20-25 mmol/L
Mg++ = 1.35-1.65 mmol/L
Cl- = 22 mmol/L
Acetate = 23 mmol/L  *Primary Health Care",B05BB02
Balanced Multiple Maintenance Solution + Dextrose,Inj.:,"with 5% Dextrose, in 1 L Bottle/Bag (IV infusion) (Children & Adults) composed of:
Dextrose = 50 g/L
Na+ = 40-50 mmol/L
K+ = 13-30 mmol/L
Mg++ = 1.65 mmol/L
Cl- = 40 mmol/L
Acetate = 16 mmol/L *Primary Health Care",B05BB02
Balanced Multiple Replacement Solution,Inj.:,"in 500 mL Bottle/Bag (IV infusion) composed of:
Na+ = 140-145 mmol/L
K+ = 4-5 mmol/L
Mg++ = 1-1.65 mmol/L
Cl- = 98-127 mmol/L
Acetate = 24-50 mmol/L
Dextrose = 50 g/L (5%) *Primary Health Care",B05BB02
Balanced Multiple Replacement Solution,Inj.:,"in 1 L Bottle/Bag (IV infusion) composed of:
Na+ = 140-145 mmol/L
K+ = 4-5 mmol/L
Mg++ = 1-1.65 mmol/L
Cl- = 98-127 mmol/L
Acetate = 24-50 mmol/L
Dextrose = 50 g/L (5%) *Primary Health Care",B05BB02
Balanced Multiple Replacement Solution (pH 7.4),Inj.:,"in 500 mL Bottle/Bag (IV infusion) composed of:
Na+ = 140 mmol/L
K+ = 5 mmol/L
Mg++ = 3 mmol/L
Cl- = 98 mmol/L
Acetate = 50 mmol/L ",B05BB02
Balanced Multiple Replacement Solution (pH 7.4),Inj.:,"in 1 L Bottle/Bag (IV infusion) composed of:
Na+ = 140 mmol/L
K+ = 5 mmol/L
Mg++ = 3 mmol/L
Cl- = 98 mmol/L
Acetate = 50 mmol/L ",B05BB02
Barium,Oral:,"(as Sulfate) Powder in 340 g Pouch, LDPE bag USP Grade suspended in water ",V08BA01
Barium,Oral:,"(as Sulfate) Powder in 454 g Pouch, LDPE bag USP Grade suspended in water ",V08BA01
Basiliximab,Inj.:,20 mg Vial (IV infusion) ,L04AC02
BCG Vaccine,Inj.:,100 mcg/0.1 mL Freeze dried powder in 1 mL Vial (ID) *Primary Health Care,L03AX03
BCG Vaccine,Inj.:,100 mcg/0.1 mL Freeze dried powder in 1.5 mL Vial (ID) *Primary Health Care,L03AX03
BCG Vaccine,Inj.:,100 mcg/0.1 mL Freeze dried powder in 2 mL Vial (ID) *Primary Health Care,L03AX03
BCG Vaccine,Inj.:,500 mcg/mL Vial + Diluent in ampul (ID) 20 doses *Primary Health Care,L03AX03
Bedaquiline,Oral:,100 mg (as Fumarate) Tablet ,J04AK05
Benzoyl peroxide,Topical:,5% Gel in 20 g Tube ,D10AE01
Benzoyl peroxide,Topical:,25% Lotion in 60 mL Bottle ,D10AE01
Benzoyl peroxide,Topical:,25% Lotion in 120 mL Bottle ,D10AE01
Beractant,Inj.:,25 mg/mL Suspension in 4 mL Vial (Intratracheal administration) ,R07AA 
Beractant,Inj.:,25 mg/mL Suspension in 8 mL Vial (Intratracheal administration) ,R07AA 
Betahistine,Oral:,8 mg (as Hydrochloride/Dihydrochloride) Tablet *Primary Health Care,N07CA01
Betahistine,Oral:,16 mg (as Hydrochloride/Dihydrochloride) Tablet *Primary Health Care,N07CA01
Betahistine,Oral:,24 mg (as Hydrochloride/Dihydrochloride) Tablet ,N07CA01
Betamethasone,Topical:,0.05% (as Dipropionate) Cream/Ointment in 5 g Tube ,D07XC01
Betamethasone,Topical:,0.05% (as Dipropionate) Cream/Ointment in 10 g Tube ,D07XC01
Betamethasone,Topical:,0.1% (as Valerate) Cream/Ointment in 5 g Tube ,D07XC01
Betaxolol,Ophthalmic:,0.25% (as Hydrochloride) Solution/Suspension in 5 mL drops ,C07AB05
Betaxolol,Ophthalmic:,0.5% (as Hydrochloride) Solution/Suspension in 5 mL drops ,C07AB05
Betaxolol,Ophthalmic:,0.5% (as Hydrochloride) Solution in 10 mL drops ,C07AB05
Bicalutamide,Oral:,50 mg Tablet/Film-coated tablet ,L02BB03
Bicalutamide,Oral:,150 mg Tablet/Film-coated tablet ,L02BB03
Biperiden,Oral:,2 mg (as Hydrochloride) Tablet *Primary Health Care,N04AA02
Biperiden,Inj.:,"5 mg/mL (as Lactate) in 1 mL Ampul (IM, IV) ",N04AA02
Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 5 mL Vial (SC) *Primary Health Care,A10AD01
Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 10 mL Vial (SC) *Primary Health Care,A10AD01
Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 3 mL Disposable syringe (SC) *Primary Health Care,A10AD01
Biphasic Isophane Human Insulin (Recombinant DNA),Inj.:,100 IU/mL (as 70% isophane suspension + 30% soluble insulin) in 3 mL Glass cartridge (SC) *Primary Health Care,A10AD01
Bisacodyl,Oral:,5 mg Tablet *Primary Health Care,A06AG02
Bisacodyl,Oral:,5 mg Modified Release (MR) tablet *Primary Health Care,A06AG02
Bisacodyl,Rectal:,5 mg Suppository (children) *Primary Health Care,A06AG02
Bisacodyl,Rectal:,10 mg Suppository (adult) *Primary Health Care,A06AG02
Bisoprolol,Oral:,2.5 mg (as Fumarate) Tablet ,C07AB07
Bisoprolol,Oral:,5 mg (as Fumarate) Tablet ,C07AB07
Bleomycin,Inj.:,"15 IU (as Sulfate) Powder Ampul/Vial (IM, IV) ",L01DC01
Brimonidine,Ophthalmic:,0.15% (as Tartrate) Ophthalmic solution in 5 mL Bottle ,S01EA05
Brinzolamide,Ophthalmic:,1% Ophthalmic suspension in 5 mL Bottle ,S01EC04
Bromazepam,Oral:,1.5 mg Tablet ,N05BA08
Bromocriptine,Oral:,2.5 mg (as Mesilate) Tablet ,G02CB01
Budesonide,Inhalation:,"100 mcg/dose x 200 doses, DPI with appropriate accompanying dispenser  ",R03BA02
Budesonide,Inhalation:,"200 mcg/dose x 100 doses, DPI with appropriate accompanying dispenser  ",R03BA02
Budesonide,Inhalation:,"200 mcg/dose x 120 actuations, MDI with appropriate accompanying dispenser  ",R03BA02
Budesonide,Inhalation:,250 mcg/mL in 2 mL Unit dose ,R03BA02
Budesonide + Formoterol,Inhalation:,"80 mcg + 4.5 mcg (as Fumarate dihydrate) x 60 doses, DPI with appropriate accompanying dispenser  ",R03AK07
Budesonide + Formoterol,Inhalation:,"160 mcg + 4.5 mcg (as Fumarate dihydrate) x 60 doses, DPI with appropriate accompanying dispenser  ",R03AK07
Budesonide + Formoterol,Inhalation:,"320 mcg + 9 mcg (as Fumarate dihydrate) x 60 doses, DPI with appropriate accompanying dispenser  ",R03AK07
Budesonide + Formoterol,Inhalation:,"80 mcg + 4.5 mcg (as Fumarate dihydrate) x 120 doses, MDI with appropriate accompanying dispenser  ",R03AK07
Budesonide + Formoterol,Inhalation:,"160 mcg + 4.5 mcg (as Fumarate dihydrate) x 120 doses, MDI with appropriate accompanying dispenser  ",R03AK07
Bumetanide,Oral:,1 mg Tablet ,C03CA02
Bumetanide,Inj.:,"500 mcg/mL in 4 mL Ampul (IM, IV) ",C03CA02
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 5 mL Vial ,N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 10 mL Vial ,N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 20 mL Vial ,N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 5 mL Ampul/Vial (local infiltration) ,N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 10 mL Ampul/Vial (local infiltration) ,N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 20 mL Ampul/Vial (local infiltration) ,N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 50 mL Ampul/Vial (local infiltration) ,N01BB01
Bupivacaine,Inj.:,"0.5% (as Hydrochloride) with 8% dextrose, in 4 mL Ampul (spinal) ",N01BB01
Bupivacaine,Inj.:,0.5% (as Hydrochloride) in 5 mL Ampul (isobaric) (spinal) ,N01BB01
Butamirate,Oral:,50 mg (as Citrate) Modified Release (MR) tablet *Primary Health Care,R05DB13
Butamirate,Oral:,7.5 mg/5 mL (as Citrate) Syrup in 120 mL *Primary Health Care,R05DB13
Butorphanol,Inj.:,"2 mg/mL in 1 mL Ampul/Vial (IM, IV) ",N02AF01
Butorphanol,Inj.:,"2 mg/mL in 2 mL Ampul/Vial (IM, IV) ",N02AF01
Calamine,Topical:,8% Lotion in 60 mL (plain) *Primary Health Care,D04AX 
Calamine,Topical:,8% Lotion in 120 mL (plain) *Primary Health Care,D04AX 
Calcipotriol,Topical:,50 mcg/g Ointment in 30 g Tube/Bottle ,D05AX02
Calcipotriol + Betamethasone,Topical:,"50 mcg (as Hydrate) + 500 mcg (as Dipropionate) per g, Ointment in 30 g Tube ",D05AX52
Calcitriol,Oral:,0.25 mcg Capsule ,A11CC04
Calcium,Oral:,(equiv. to 500 mg elemental calcium) (as Lactate) Tablet ,A12AA05 
Calcium,Oral:,(equiv. to 500 mg elemental calcium) (as Carbonate) Tablet/Chewable tablet *Primary Health Care,A12AA04 
Calcium,Oral:,(equiv. to 600 mg elemental calcium) (as Carbonate) Tablet/Chewable tablet *Primary Health Care,A12AA04 
Calcium,Oral:,(as Chloride) Powder USP Grade ,A12AA07 
Calcium,Inj.:,10% (as Gluconate) Solution in 10 mL Ampul (IV) ,A12AA03 
Calcium,Inj.:,10% (as Gluconate) in 10 mL Ampul/Vial (IV) *Primary Health Care,A12AA03 
Calcium,Inj.:,10% (as Gluconate) in 20 mL Bottle (IV) *Primary Health Care,A12AA03 
Calcium,Inj.:,10% (as Gluconate) in 25 mL Bottle (IV) *Primary Health Care,A12AA03 
Calcium (Leucovorin Calcium),Inj.:,"10 mg/mL (as Folinate) in 5 mL Ampul/Vial (IM, IV) ",V03AF03
Calcium (Leucovorin Calcium),Inj.:,"10 mg/mL (as Folinate) in 50 mg Vial (IM, IV) ",V03AF03
Calcium + Cholecalciferol/Vitamin D3,Oral:,(equiv. to 500 mg elemental calcium) (as Carbonate) + 400 IU *Primary Health Care,A12AX
Calcium + Cholecalciferol/Vitamin D3,Oral:,(equiv. to 600 mg elemental calcium) (as Carbonate) + 400 IU *Primary Health Care,A12AX
Calcium Sennosides,Oral:,8.77 mg (equiv. to standardized senna concentrate) Tablet ,A06AB56
Calcium Sennosides,Oral:,17.54 mg (equiv. to standardized senna concentrate) Tablet ,A06AB56
Capecitabine,Oral:,150 mg Tablet ,L01BC06
Capecitabine,Oral:,500 mg Tablet ,L01BC06
Capreomycin,Inj.:,"1 g Powder for injection (IM, IV) ",J04AB30
Captopril,Oral:,25 mg Tablet *Primary Health Care,C09AA01
Captopril,Oral:,50 mg Tablet ,C09AA01
Carbachol,Ophthalmic:,0.01% Intraocular solution in 1.5 mL Vial ,N07AB01
Carbamazepine,Oral:,200 mg Tablet *Primary Health Care,N03AF01
Carbamazepine,Oral:,200 mg Modified Release (MR) tablet *Primary Health Care,N03AF01
Carbamazepine,Oral:,400 mg Modified Release (MR) tablet *Primary Health Care,N03AF01
Carbamazepine,Oral:,100 mg/5 mL Syrup in 120 mL *Primary Health Care,N03AF01
Carbetocin,Inj.:,100 mcg/mL Solution for injection in 1 mL Ampul/Vial (IV) ,H01BB03
Carboplatin,Inj.:,150 mg Powder Vial (IV) ,L01XA02
Carboplatin,Inj.:,450 mg Powder Vial (IV) ,L01XA02
Carboplatin,Inj.:,10 mg/mL in 15 mL Vial (IV) ,L01XA02
Carboplatin,Inj.:,10 mg/mL in 45 mL Vial (IV) ,L01XA02
Carboprost,Inj.:,125 mcg/0.5 mL Solution for injection in 0.5 mL Ampul/Vial ,G02AD04
Carboprost,Inj.:,250 mcg/mL Solution for injection in 1 mL Ampul/Vial ,G02AD04
Carboxymethylcellulose,Ophthalmic:,0.5% Solution in 0.4 mL Solution for eye drops ,S01XA20
Carboxymethylcellulose,Ophthalmic:,0.5% Solution in 15 mL Solution for eye drops Drops ,S01XA20
Carvedilol,Oral:,6.25 mg Tablet ,C07AG02
Carvedilol,Oral:,25 mg Tablet ,C07AG02
Castor Oil,Oral:,USP Grade ,A06AB05
Cefalexin,Oral:,500 mg (as Monohydrate) Capsule *Primary Health Care,J01DB01
Cefalexin,Oral:,100 mg/mL (as Monohydrate) Granules/Powder for drops in 10 mL *Primary Health Care,J01DB01
Cefalexin,Oral:,125 mg/5 mL (as Monohydrate) Granules/Powder for suspension/syrup in 30 mL *Primary Health Care,J01DB01
Cefalexin,Oral:,250 mg/5 mL (as Monohydrate) Granules/Powder for suspension/syrup in 60 mL *Primary Health Care,J01DB01
Cefazolin,Inj.:,"500 mg (as Sodium) Vial (IM, IV) ",J01DB04
Cefazolin,Inj.:,"1 g (as Sodium) Vial (IM, IV) ",J01DB04
Cefepime *Reserve antimicrobial,Inj.:,"500 mg (as Hydrochloride) Vial (IM, IV) ",J01DE01
Cefepime *Reserve antimicrobial,Inj.:,"1 g (as Hydrochloride) Vial (IM, IV) ",J01DE01
Cefepime *Reserve antimicrobial,Inj.:,"2 g (as Hydrochloride) Vial (IM, IV) ",J01DE01
Cefixime,Oral:,200 mg Capsule *Primary Health Care,J01DD08
Cefixime,Oral:,400 mg Capsule ,J01DD08
Cefixime,Oral:,20 mg/mL in 10 mL (drops) *Primary Health Care,J01DD08
Cefixime,Oral:,100 mg/5 mL Granules for Suspension in 60 mL *Primary Health Care,J01DD08
Cefotaxime,Inj.:,"250 mg (as Sodium) Vial + 2 mL diluent (IM, IV) ",J01DD01
Cefotaxime,Inj.:,"500 mg (as Sodium) Vial + 2 mL diluent (IM, IV) ",J01DD01
Cefoxitin,Inj.:,"1 g (as Sodium) Vial (IM, IV) ",J01DC01
Cefoxitin,Inj.:,1 g (as Sodium) Powder for injection + 4% dextrose solution for injection (IV infusion) ,J01DC01
Ceftazidime (Ceftaxidime),Inj.:,"250 mg (as Pentahydrate) Vial (IM, IV) ",J01DD02
Ceftazidime (Ceftaxidime),Inj.:,"500 mg (as Pentahydrate) Vial (IM, IV) ",J01DD02
Ceftazidime (Ceftaxidime),Inj.:,"1 g (as Pentahydrate) Vial (IM, IV) ",J01DD02
Ceftazidime (Ceftaxidime),Inj.:,2 g (as Pentahydrate) Vial (IV infusion) ,J01DD02
Ceftriaxone,Inj.:,250 mg (as Sodium/Disodium) Vial + 2 mL 1% solution of lidocaine (IM) *Primary Health Care,J01DD04
Ceftriaxone,Inj.:,500 mg (as Sodium/Disodium) Vial + 2 mL 1% solution of lidocaine (IM) *Primary Health Care,J01DD04
Ceftriaxone,Inj.:,250 mg (as Sodium/Disodium) Vial + 5 mL diluent (IV) *Primary Health Care,J01DD04
Ceftriaxone,Inj.:,1 g (as Sodium/Disodium) Vial + 3.5 mL 1% solution of lidocaine (IM) *Primary Health Care,J01DD04
Ceftriaxone,Inj.:,1 g (as Sodium/Disodium) Vial + 10 mL diluent (IV) ,J01DD04
Cefuroxime,Oral:,500 mg (as Axetil) Tablet *Primary Health Care,J01DC02
Cefuroxime,Oral:,125 mg/5 mL (as Axetil) Granules for Suspension in 70 mL *Primary Health Care,J01DC02
Cefuroxime,Oral:,250 mg/5 mL Granules for Suspension in 50 mL in 120 mL Bottle *Primary Health Care,J01DC02
Cefuroxime,Inj.:,"250 mg Vial (IM,IV) ",J01DC02
Cefuroxime,Inj.:,"750 mg Vial (IM,IV) ",J01DC02
Cefuroxime,Inj.:,1.5 g (as Sodium) Vial (IV infusion) ,J01DC02
Celecoxib,Oral:,100 mg Capsule *Primary Health Care,M01AH01
Celecoxib,Oral:,200 mg Capsule *Primary Health Care,M01AH01
Celecoxib,Oral:,400 mg Capsule *Primary Health Care,M01AH01
Cetirizine,Oral:,10 mg (as Dihydrochloride) Tablet *Primary Health Care,R06AE07
Cetirizine,Oral:,2.5 mg/mL (as Dihydrochloride) Syrup in 10 mL Drops ,R06AE07
Cetirizine,Oral:,10 mg/mL (as Dihydrochloride) in 10 mL Drops ,R06AE07
Cetirizine,Oral:,1 mg/mL (as Dihydrochloride) Solution in 30 mL *Primary Health Care,R06AE07
Cetirizine,Oral:,1 mg/mL (as Dihydrochloride) Solution in 60 mL *Primary Health Care,R06AE07
Cetirizine,Oral:,5 mg/ 5mL (as Dihydrochloride) Syrup in 30 mL *Primary Health Care,R06AE07
Chlorambucil,Oral:,2 mg Tablet ,L01AA02
Chloramphenicol,Oral:,500 mg Capsule *Primary Health Care,J01BA01
Chloramphenicol,Oral:,125 mg/5 mL (as Palmitate) Suspension in 60 mL *Primary Health Care,J01BA01
Chloramphenicol,Inj.:,1 g (as Sodium succinate) Vial (IV; IM if recommended by manufacturer) ,J01BA01
Chlorhexedine,,0.12% (as Gluconate) Solution in 50 mL ,D08AC02
Chlorhexedine,,0.12% (as Gluconate) Solution in 120 mL ,D08AC02
Chlorhexedine,,0.12% (as Gluconate) Solution in 380 mL ,D08AC02
Chlorhexedine,,0.12% (as Gluconate) Solution in 500 mL ,D08AC02
Chlorhexedine,,0.12% (as Gluconate) Solution in 4 L ,D08AC02
Chlorhexedine,,0.12% (as Gluconate) Solution in 5 L ,D08AC02
Chlorhexedine,,4% (as Gluconate) Solution in 50 mL ,D08AC02
Chlorhexedine,,4% (as Gluconate) Solution in 120 mL ,D08AC02
Chlorhexedine,,4% (as Gluconate) Solution in 380 mL ,D08AC02
Chlorhexedine,,4% (as Gluconate) Solution in 500 mL ,D08AC02
Chlorhexedine,,4% (as Gluconate) Solution in 4 L ,D08AC02
Chlorhexedine,,4% (as Gluconate) Solution in 5 L ,D08AC02
Chloroquine,Oral:,250 mg (150 mg base) (as Phosphate/Diphosphate) Tablet *Primary Health Care,P01BA01
Chloroquine,Inj.:,"50 mg/mL (as Phosphate/Diphosphate) in 20 mL Vial (IM,IV) ",P01BA01
Chlorphenamine (Chlorpheniramine),Oral:,4 mg (as Maleate) Tablet ,R06AB04
Chlorphenamine (Chlorpheniramine),Oral:,2.5 mg/5 mL (as Maleate) Syrup in 60 mL ,R06AB04
Chlorphenamine (Chlorpheniramine),Inj.:,"10 mg/mL (as Maleate) in 1 mL (IM,IV) ",R06AB04
Chlorpromazine,Oral:,100 mg (as Hydrochloride) Tablet *Primary Health Care,N05AA01
Chlorpromazine,Oral:,200 mg (as Hydrochloride) Tablet *Primary Health Care,N05AA01
Chlorpromazine,Oral:,50 mg (as Hydrochloride) Tablet *Primary Health Care,N05AA01 
Chlorpromazine,Inj.:,25 mg/mL (as Hydrochloride) in 1 mL Ampul *Primary Health Care,N05AA01 
Ciclosporin,Oral:,25 mg Capsule ,L04AD01
Ciclosporin,Oral:,50 mg Capsule ,L04AD01
Ciclosporin,Oral:,100 mg Capsule ,L04AD01
Ciclosporin,Oral:,100 mg/mL Solution in 50 mL ,L04AD01
Ciclosporin,Ophthalmic:,0.05% Ophthalmic emulsion in 0.4 mL Bottle ,L04AD01
Cilostazol,Oral:,50 mg Tablet ,B01AC23
Cilostazol,Oral:,100 mg Tablet ,B01AC23
Cilostazol,Oral:,50 mg (20% w/w) Powder in 0.25 g Sachet ,B01AC23
Cilostazol,Oral:,100 mg (20% w/w) Powder in 0.5 g Sachet ,B01AC23
Cinnarizine,Oral:,25 mg Tablet ,N07CA02
Ciprofloxacin,Oral:,250 mg (as Hydrochloride) Tablet *Primary Health Care,J01MA02
Ciprofloxacin,Oral:,500 mg (as Hydrochloride) Tablet *Primary Health Care,J01MA02
Ciprofloxacin,Inj.:,2 mg/mL (as Lactate) in 100 mL Vial + (IV infusion) ,J01MA02
Ciprofloxacin,Inj.:,400 mg/200 mL + (IV infusion) ,J01MA02
Cisplatin,Inj.:,1 mg/mL in 10 mL Vial + (IV) ,L01XA01
Cisplatin,Inj.:,1 mg/mL in 50 mL Vial + (IV) ,L01XA01
Clarithromycin,Oral:,250 mg Tablet (Base) *Primary Health Care,J01FA09
Clarithromycin,Oral:,500 mg Tablet (Base) *Primary Health Care,J01FA09
Clarithromycin,Oral:,125 mg/5 mL Granules/Powder for suspension in 50 mL *Primary Health Care,J01FA09
Clarithromycin,Oral:,250 mg/5 mL Granules/Powder for suspension in 50 mL *Primary Health Care,J01FA09
Clindamycin,Oral:,150 mg (as Hydrochloride) Capsule *Primary Health Care,J01FF01
Clindamycin,Oral:,300 mg (as Hydrochloride) Capsule *Primary Health Care,J01FF01
Clindamycin,Oral:,75 mg/5 mL (as Palmitate hydrochloride) Granules for suspension in 60 mL *Primary Health Care,J01FF01
Clindamycin,Inj.:,"150 mg/mL (as Phosphate) in 2 mL Ampul/Vial (IM, IV) ",J01FF01
Clindamycin,Inj.:,"150 mg/mL (as Phosphate) in 4 mL Ampul (IM, IV) ",J01FF01
Clobetasol,Topical:,0.05% (as Propionate) Cream/Ointment in 5 g Tube ,D07AD01
Clobetasol,Topical:,0.05% (as Propionate) Cream/Ointment in 15 g Tube ,D07AD01
Clobetasol,Topical:,0.05% (as Propionate) Shampoo in 25 mL Bottle ,D07AD01
Clofazimine,Oral:,50 mg Capsule *Primary Health Care,J04BA01
Clofazimine,Oral:,100 mg Capsule *Primary Health Care,J04BA01
Clomifene,Oral:,50 mg (as Citrate) Tablet ,G03GB02
Clonazepam,Oral:,500 mcg Tablet ,N03AE01
Clonazepam,Oral:,2 mg Tablet ,N03AE01
Clonidine,Oral:,75 mcg (as Hydrochloride) Tablet *Primary Health Care,C02AC01
Clonidine,Oral:,150 mcg (as Hydrochloride) Tablet ,C02AC01
Clonidine,,150 mcg/mL (as Hydrochloride) in 1 mL Ampul (IV) ,C02AC01
Clopidogrel,Oral:,75 mg Tablet *Primary Health Care,B01AC04
Clotrimazole,Topical:,1% (10 mg/g) Cream in 3 g Aluminum collapsible tube *Primary Health Care,G01AF02
Clotrimazole,Topical:,1% (10 mg/g) Cream in 10 g Aluminum collapsible tube *Primary Health Care,G01AF02
Clotrimazole,Topical:,1% (10 mg/g) Cream in 20 g Aluminum collapsible tube *Primary Health Care,G01AF02
Clotrimazole,Topical:,2% (20 mg/g) Cream in 30 g Aluminum collapsible tube *Primary Health Care,G01AF02
Clotrimazole,Vaginal:,1% Cream in 10 g Aluminum collapsible tube *Primary Health Care,G01AF02
Clotrimazole,Otic:,1% Solution *Primary Health Care,G01AF02
Cloxacillin,Oral:,500 mg (as Sodium) Capsule *Primary Health Care,J01CF02
Cloxacillin,Oral:,250 mg/5 mL (as Sodium) Powder for solution in 60 mL *Primary Health Care,J01CF02
Clozapine,Oral:,25 mg Tablet (Requires hematologic monitoring) *Primary Health Care,N05AH02
Clozapine,Oral:,100 mg Tablet (Requires hematologic monitoring) *Primary Health Care,N05AH02
Cobra Antivenin,Inj.:,800 MU/4.8 mL in 1 mL Ampul (IV infusion) *Primary Health Care,J06AA03
Cobra Antivenin,Inj.:,800 IU/mL in 5 mL Ampul (IV infusion) ,J06AA03
Codeine + A1,Oral:,30 mg (as Phosphate) Modified Release (MR) capsule ,R05DA04
Codeine + A1,Oral:,10 mg/5 mL Suspension in 60 mL ,R05DA04
Colchicine,Oral:,500 mcg Tablet ,M04AC01
Colistin *Reserve antimicrobial,Inj.:,"2,000,000 IU Lyophilized powder for injection (IV infusion) ",J01XB01
Combined Glucose-Amino Acid Solutions,,"in 100 mL composed of:
Concentration - Variable
Glucose (Sorbitol) = 25-50 g
Protein = 20-30 g
Calories = 300-450 Kcal
Electrolytes = Variable ",B05BA10
Combined Glucose-Amino Acid Solutions,,"in 500 mL composed of:
Concentration - Variable
Glucose (Sorbitol) = 25-50 g
Protein = 20-30 g
Calories = 300-450 Kcal
Electrolytes = Variable ",B05BA10
Conjugated Estrogen,Oral:,625 mcg Tablet ,G03CA57
Conjugated Estrogen,Oral:,1.25 mg Tablet ,G03CA57
Crotamiton,Topical:,10% Lotion in 60 mL ,P03AX 
Cyclophosphamide,Inj.:,200 mg Powder Vial (IV) ,L01AA01
Cyclophosphamide,Inj.:,500 mg Powder Vial (IV) ,L01AA01
Cyclophosphamide,Inj.:,1 g Powder Vial (IV) ,L01AA01
Cycloserine,Oral:,250 mg Capsule ,J04AB01
Cyproterone,Oral:,50 mg (as Acetate) Tablet ,G03HA01
Cytarabine,Inj.:,"20 mg/mL in 5 mL Ampul (IM, SC, Intrathecal) ",L01BC01
Cytarabine,Inj.:,100 mg/mL Solution for injection in 1 mL ,L01BC01
Cytarabine,Inj.:,100 mg/mL Solution for injection in 5 mL ,L01BC01
Cytarabine,Inj.:,100 mg/mL Solution for injection in 10 mL ,L01BC01
Dabigatran,Oral:,110 mg Capsule ,B01AE07 
Dabigatran,Oral:,150 mg Capsule ,B01AE07 
Dacarbazine,Inj.:,"100 mg Powder Vial (IV,IV infusion) ",L01AX04
Dacarbazine,Inj.:,"200 mg Powder Vial (IV,IV infusion) ",L01AX04
Daclatasvir,Oral:,60 mg Tablet ,J05AP07
Dactinomycin,Inj.:,500 mcg Powder Vial (IV) ,L01DA01
Danazol,Oral:,200 mg Capsule ,G03XA01
Dantrolene,Oral:,25 mg (as Sodium) Capsule ,M03CA01
Dantrolene,Oral:,50 mg (as Sodium) Capsule ,M03CA01
Dantrolene,Inj.:,20 mg  (as Sodium) Vial with mannitol 3 g (IV) ,M03CA01
Dapagliflozin,Oral:,10 mg Film-coated tablet ,A10BK01 
Dapsone,Oral:,100 mg Tablet *Primary Health Care,J04BA02
Deferasirox,Oral:,125 mg Dispersible tablet ,V03AC03
Deferasirox,Oral:,250 mg Dispersible tablet ,V03AC03
Deferasirox,Oral:,90 mg Film-coated tablet ,V03AC03 
Deferasirox,Oral:,180 mg Film-coated tablet ,V03AC03 
Deferiprone,Oral:,500 mg Tablet ,V03AC02
Deferoxamine,Inj.:,"500 mg (as Mesilate) Vial (IM, IV infusion, SC) ",V03AC01
Delamanid,Oral:,50 mg Film-coated tablet ,J04AK06
Desflurane,Inhalation:,in 240 mL Bottle ,N01AB07
Desmopressin,Oral:,100 mcg (as Acetate) Tablet ,H01BA02
Desmopressin,Oral:,200 mcg (as Acetate) Tablet ,H01BA02
Desmopressin,Inj.:,"15 mcg/mL (as Acetate) in 1 mL Ampul (IM, SC) ",H01BA02
Dexamethasone,Oral:,500 mcg Tablet *Primary Health Care,S02BA06
Dexamethasone,Oral:,750 mcg Tablet ,S02BA06
Dexamethasone,Oral:,3 mg Tablet ,S02BA06
Dexamethasone,Oral:,4 mg Tablet *Primary Health Care,S02BA06
Dexamethasone,Inj.:,"4 mg/mL (as Sodium phosphate) in 1 mL Ampul/Vial (IM, IV) ",S02BA06
Dexamethasone,Inj.:,"4 mg/mL (as Sodium phosphate) in 2 mL Ampul/Vial (IM, IV) ",S02BA06
Dexamethasone,Inj.:,"5 mg/mL (as Sodium phosphate) Solution for IV infusion in 1 mL Ampul (IM,IV) *Primary Health Care",S02BA06
Dexamethasone,Ophthalmic:,0.1% Suspension for eye drops in 5 mL ,S02BA06
"Dextran, High Molecular Weight",Inj.:,"6% (as Dextran 70) in 0.9% Sodium chloride, in 500 mL (IV infusion) ",B05AA05
"Dextran, High Molecular Weight",Inj.:,"6% (as Dextran 70) in 5% Dextrose, in 500 mL (IV infusion) ",B05AA05
Dextromethorphan,Oral:,10 mg (as Hydrobromide) Tablet ,R05DA09
Dextrose,Inj.:,"5% in 0.3% Sodium chloride, in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 51 mmol/L
Cl- = 51 mmol/L ",V06DC01
Dextrose,Inj.:,"5% in 0.3% Sodium chloride, in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 51 mmol/L
Cl- = 51 mmol/L ",V06DC01
Dextrose,Inj.:,"5% in 0.3% Sodium chloride, in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 51 mmol/L
Cl- = 51 mmol/L ",V06DC01
Dextrose,Inj.:,"5% in 0.45% Sodium chloride, in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 77 mmol/L
Cl- = 77 mmol/L ",V06DC01
Dextrose,Inj.:,"5% in 0.45% Sodium chloride, in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 77 mmol/L
Cl- = 77 mmol/L ",V06DC01
Dextrose,Inj.:,"5% in 0.45% Sodium chloride, in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 77 mmol/L
Cl- = 77 mmol/L ",V06DC01
Dextrose,Inj.:,"5% in 0.9% Sodium chloride, in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 154 mmol/L
Cl- = 154 mmol/L *Primary Health Care",V06DC01
Dextrose,Inj.:,"5% in 0.9% Sodium chloride, in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 154 mmol/L
Cl- = 154 mmol/L *Primary Health Care",V06DC01
Dextrose,Inj.:,"5% in 0.9% Sodium chloride, in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 154 mmol/L
Cl- = 154 mmol/L *Primary Health Care",V06DC01
Dextrose,Inj.:,"5% in Lactated ringers in 250 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22-1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",V06DC01
Dextrose,Inj.:,"5% in Lactated ringers in 500 mL Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22-1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",V06DC01
Dextrose,Inj.:,"5% in Lactated ringers in 1 L Bottle/Bag (IV infusion) composed of:
Dextrose = 50 g/L
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22-1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",V06DC01
Dextrose,Inj.:,5% in Water in 250 mL Bottle/Bag (IV infusion and as vehicle for IV medications) *Primary Health Care,V06DC01
Dextrose,Inj.:,5% in Water in 500 mL Bottle/Bag (IV infusion and as vehicle for IV medications) ,V06DC01
Dextrose,Inj.:,5% in Water in 1 L Bottle/Bag (IV infusion and as vehicle for IV medications) ,V06DC01
Dextrose,,10% in Water in 250 mL Bottle/Bag (IV infusion) ,V06DC01
Dextrose,Inj.:,10% in Water in 500 mL Bottle/Bag (IV infusion) ,V06DC01
Dextrose,Inj.:,10% in Water in 1 L Bottle/Bag (IV infusion) ,V06DC01
Dextrose,Inj.:,10% in Water in 3 mL Ampul (As solvent) ,V06DC01
Diazepam,Oral:,5 mg Tablet *Primary Health Care,N05BA01
Diazepam,Inj.:,"5 mg/mL in 2 mL Ampul (IM,IV) *Primary Health Care",N05BA01
Diclofenac,Oral:,25 mg (as Sodium/Potassium) Tablet/Capsule ,M01AB05
Diclofenac,Oral:,50 mg (as Sodium/Potassium) Tablet/Capsule ,M01AB05
Diclofenac,Oral:,50 mg (as Sodium) Enteric-coated/Modified Release (MR) tablet ,M01AB05
Diclofenac,Oral:,100 mg (as Sodium/Potassium) Modified Release (MR) tablet/Capsule ,M01AB05
Diclofenac,Inj.:,"25 mg/mL (as Sodium) in 3 mL Ampul (IM, IV) ",M01AB05
Dicycloverine (Dicyclomine),Oral:,10 mg (as Hydrochloride) Tablet *Primary Health Care,A03AA07
Dicycloverine (Dicyclomine),Oral:,10 mg/5 mL (as Hydrochloride) Syrup in 60 mL *Primary Health Care,A03AA07
Diethylcarbamazine,Oral:,50 mg Tablet *Primary Health Care,P02CB02
Diethylcarbamazine,Oral:,100 mg Tablet ,P02CB02
Digoxin,Oral:,250 mcg Tablet *Primary Health Care,C01AA05
Digoxin,Oral:,50 mcg/mL Elixir in 60 mL ,C01AA05
Digoxin,Inj.:,"250 mcg/mL in 2 mL Ampul (IM, IV) ",C01AA05
Diloxanide,Oral:,500 mg (as Furoate) Tablet ,P01AC01
Diloxanide,Oral:,125 mg/5 mL (as Furoate) Syrup/Suspension in 30 mL ,P01AC01
Diloxanide,Oral:,125 mg/5 mL (as Furoate) Syrup/Suspension in 60 mL ,P01AC01
Diltiazem,Oral:,60 mg (as Hydrochloride) Tablet *Primary Health Care,C08DB01
Diltiazem,Oral:,60 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01
Diltiazem,Oral:,120 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01
Diltiazem,Oral:,180 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01
Diltiazem,Oral:,240 mg (as Hydrochloride) Modified Release (MR) capsule ,C08DB01
Diltiazem,Oral:,120 mg (as Hydrochloride) Modified Release (MR) tablet *Primary Health Care,C08DB01
Diltiazem,Oral:,180 mg (as Hydrochloride) Modified Release (MR) tablet *Primary Health Care,C08DB01
Diltiazem,Oral:,30 mg (as Hydrochloride) Tablet *Primary Health Care,C08DB01 
Diltiazem,Oral:,90 mg (as Hydrochloride) Modified Release (MR) capsule *Primary Health Care,C08DB01 
Diltiazem,Oral:,90 mg (as Hydrochloride) Modified Release (MR) tablet *Primary Health Care,C08DB01 
Dimeglumine Gadopentate,Inj.:,469 mg/mL Aqueous solution in 5 mL Vial ,V08CA01
Dimeglumine Gadopentate,Inj.:,469 mg/mL Aqueous solution in 10 mL Vial ,V08CA01
Dimeglumine Gadopentate,Inj.:,469 mg/mL Aqueous solution in 20 mL Vial ,V08CA01
Dimercaprol,Inj.:,"50 mg/mL in Oil, in 2 mL Ampul (IM) ",V03AB09
Dimercaptopropane-sulfonate (DMPS),Inj.:,100 mg/mL in 1 mL Ampul (IM) ,V03AB 
Dimercaptopropane-sulfonate (DMPS),Inj.:,100 mg/mL in 10 mL Vial (IM) ,V03AB 
Diphenhydramine,Oral:,25 mg (as Hydrochloride) Capsule *Primary Health Care,D04AA32
Diphenhydramine,Oral:,50 mg (as Hydrochloride) Capsule *Primary Health Care,D04AA32
Diphenhydramine,Oral:,12.5 mg/mL (as Hydrochloride) Syrup in 30 mL *Primary Health Care,D04AA32
Diphenhydramine,Oral:,12.5 mg/mL (as Hydrochloride) Syrup in 60 mL *Primary Health Care,D04AA32
Diphenhydramine,Inj.:,"50 mg/mL (as Hydrochloride) in 1 mL Ampul (IM,IV) *Primary Health Care",D04AA32
Diphtheria + Tetanus + Pertussis  + Hepatitis B recombinant + Hemophilus Influenza Type B Vaccine,Inj.:,0.5 mL Suspension for injection Vial (IM) ,J07CA11
Diphtheria + Tetanus Toxoids (DT) Vaccine,Inj.:,"30 IU + 40 IU per 0.5 mL, Ampul (IM) ",J07AF01
Diphtheria + Tetanus Toxoids (Td) Vaccine,Inj.:,"≥ 2 IU + ≥ 40 IU per 0.5 mL, Ampul (IM) ",J07AF01
Diphtheria + Tetanus Toxoids (Td) Vaccine,Inj.:,"≥ 2 IU + ≥ 40 IU per 0.5 mL, Multidose vial (IM)(10 doses per vial) ",J07AF01
Diphtheria + Tetanus Toxoids + Acellular Pertussis (DTaP) Vaccine,Inj.:,0.5 mL Pre-filled syringe (IM) ,J07AJ52
Diphtheria + Tetanus Toxoids + Acellular Pertussis + Haemophilus Influenzae Type B (DTaP + Hib) Vaccine,Inj.:,0.5 mL Pre-filled syringe (IM) ,J07AG52
Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,0.5 mL Ampul (IM) *Primary Health Care,J07AJ51
Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,0.5 mL Pre-filled syringe (IM) *Primary Health Care,J07AJ51
Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 0.5 mL Vial (IM) *Primary Health Care,J07AJ51
Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 5 mL Vial (IM) *Primary Health Care,J07AJ51
Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 7.5 mL Vial (IM) *Primary Health Care,J07AJ51
Diphtheria + Tetanus Toxoids + Pertussis (DTP) Vaccine,Inj.:,in 10 mL Vial (IM) *Primary Health Care,J07AJ51
Diphtheria + Tetanus Toxoids + Pertussis + Haemophilus Influenzae Type B (DTP + Hib) Vaccine,Inj.:,"10 mcg (as Hib) Freeze-dried powder Vial + 0.5 mL DTP diluent in pre-filled syringe (IM, SC) ",J07CA11
Diphtheria + Tetanus Toxoids + Pertussis + Hepatitis B (Recombinant) Vaccine,Inj.:,"0.5 mL Vial (IM, SC) ",J07CA05
Diphtheria + Tetanus Toxoids + Pertussis + Inactivated Polio Vaccine (DTP + IPV) Vaccine,Inj.:,"0.5 mL Monodose vial (IM, SC) ",J07CA02
Diphtheria + Tetanus Toxoids + Pertussis + Inactivated Polio Vaccine (DTP + IPV) Vaccine,Inj.:,"0.5 mL Pre-filled syringe (IM, SC) ",J07CA02
Diphtheria + Tetanus Toxoids + Pertussis + Inactivated Polio Vaccine + Haemophilus Influenzae Type B (DTP + IPV + Hib) Vaccine,Inj.:,"0.5 mL Pre-filled syringe (IM, SC) ",J07CA06
Diphtheria Antitoxin,Inj.:,"10,000 IU in 5 mL (IM) ",J06AA01
Diphtheria Antitoxin,Inj.:,"10,000 IU in 10 mL (IM) ",J06AA01
Diphtheria Antitoxin,Inj.:,"20,000 IU in 5 mL (IM) ",J06AA01
Diphtheria Antitoxin,Inj.:,"20,000 IU in 10 mL (IM) ",J06AA01
Dipyridamole,Oral:,25 mg Tablet (Preferably used in combination with aspirin) ,B01AC07
Dobutamine,Inj.:,50 mg/mL (as Hydrochloride) in 5 mL Ampul (Concentrate) (IV infusion) ,C01CA07
Dobutamine,Inj.:,2 mg/mL (as Hydrochloride) + 250 mL D5W (pre-mixed) (IV) ,C01CA07
Docetaxel,Inj.:,10 mg/mL Solution for infusion in 2 mL Vial (IV infusion) ,L01CD02
Docetaxel,Inj.:,10 mg/mL Solution for infusion in 8 mL Vial (IV infusion) ,L01CD02
Docetaxel,Inj.:,20 mg/0.5 mL (as Anhydrous) in 0.5 mL Vial (IV infusion) ,L01CD02
Docetaxel,Inj.:,40 mg/mL (as Anhydrous) in 2 mL Vial (IV infusion) ,L01CD02
Docetaxel,Inj.:,20 mg/mL (as Trihydrate) Solution for IV infusion in 1 mL Vial (Concentrate) ,L01CD02
Docetaxel,Inj.:,80 mg/4 mL (as Trihydrate) Solution for IV infusion in 4 mL Vial (Concentrate) ,L01CD02
Dolutegravir,Oral:,50 mg Tablet ,J05AJ03
Domperidone,Oral:,10 mg Tablet ,A03FA03
Domperidone,Oral:,1 mg/mL Suspension in 60 mL ,A03FA03
Donepizil,Oral:,5 mg Tablet/Orodispersible tablet (ODT) ,N06DA02
Donepizil,Oral:,10 mg Tablet/Orodispersible tablet (ODT) ,N06DA02
Dopamine,Inj.:,40 mg/mL (as Hydrochloride) in 5 mL Ampul/Vial (IV) *Primary Health Care,C01CA04
Dopamine,Inj.:,800 mcg/mL (as Hydrochloride) + 250 mL D5W (pre-mixed) (IV) *Primary Health Care,C01CA04
Dopamine,Inj.:,1.6 mg/mL (as Hydrochloride) + 250 mL D5W (pre-mixed) (IV) ,C01CA04
Dopamine,Inj.:,80 mg/mL in 5 mL Vial (IV) *Primary Health Care,C01CA04 
Dorzolamide,Ophthalmic:,2% (as Hydrochloride) Ophthalmic solution in 5 mL Vial (drops) ,S01EC03
Doxorubicin,Inj.:,10 mg (as Hydrochloride) Powder Vial (IV) ,L01DB01
Doxorubicin,Inj.:,50 mg (as Hydrochloride) Powder Vial (IV) ,L01DB01
Doxorubicin,Inj.:,2 mg/mL (as Hydrochloride) in 5 mL Vial (IV) ,L01DB01
Doxorubicin,Inj.:,2 mg/mL (as Hydrochloride) in 25 mL Vial (IV) ,L01DB01
Doxycycline,Oral:,100 mg (as Hyclate) Capsule *Primary Health Care,J01AA02
Dydrogesterone,Oral:,10 mg Tablet ,G03DB01
Efavirenz,Oral:,50 mg Tablet/Capsule ,J05AG03
Efavirenz,Oral:,100 mg Tablet/Capsule ,J05AG03
Efavirenz,Oral:,200 mg Tablet/Capsule ,J05AG03
Efavirenz,Oral:,600 mg Tablet/Capsule ,J05AG03
Emtricitabine + Tenofovir,Oral:,200 mg + 300 mg (as Disoproxil fumarate) Tablet ,J05AR08
Enalapril,Oral:,5 mg (as Maleate) Tablet *Primary Health Care,C09AA02
Enalapril,Oral:,20 mg (as Maleate) Tablet *Primary Health Care,C09AA02
Enalapril + Hydrochlorothiazide,Oral:,20 mg + 12.5 mg Tablet *Primary Health Care,C09BA02
Enoxaparin,Inj.:,100 mg/mL (as Sodium) in 0.2 mL Pre-filled syringe (SC) ,B01AB05
Enoxaparin,Inj.:,100 mg/mL (as Sodium) in 0.4 mL Pre-filled syringe (SC) ,B01AB05
Enoxaparin,Inj.:,100 mg/mL (as Sodium) in 0.6 mL Pre-filled syringe (SC) ,B01AB05
Entecavir,Oral:,500 mcg Tablet/Film-coated tablet ,J05AF10
Entecavir,Oral:,1 mg/mL Tablet/Film-coated tablet ,J05AF10
Entecavir,Oral:,0.05 mg/mL Solution ,J05AF10
Enteral Nutrition - Adult Polymeric,Oral/Tube feed:,"in 100 mL-1 L composed of:
Calories = 100-475 Kcal
Dilution = 1:1-2:1
Carbohydrates = 13.9-59 g
Protein = 3.8-19.9 g
Fat = 3.4-21.5 g
mOsm/kg = 270-730
Sodium = 75-402 mg
Potassium = 370-580 mg
Calcium = 80-500 mg 
Magnesium = 25-500 mg
Fiber = 0-1.5 g
Phosphorus = 47-307 mg ",V06DB
Enteral Nutrition - Disease Specific,Oral/Tube feed:,"in 50-500 mL composed of:
Calories = 100-1000 Kcal
Dilution = 1:1-2:1
Carbohydrates = 10.4-156 g
Protein = 5.5-88 g
Fat = 3.3-108 g
mOsm/kg = 230-635
Sodium = 80-2400 mg
Potassium = 172-5600 mg
Calcium = 80-500 mg 
Magnesium = 25-500 mg
Phosphorus = 50-1789 mg
50-500 g ",V06DB
Enteral Nutrition - Fiber Containing,Oral/Tube feed:,"in 500 mL composed of:
Calories = 100-1048 Kcal
Dilution = 1:1-2:1
Carbohydrates = 13.8-148 g
Protein = 3.8-40 g
Fat = 3.4-34.7 g
mOsm/kg = 270-375
Sodium = 46.5-930 mg
Potassium = 78.5-1570 mg
Phosphorus = 63-720 mg
Fiber = 2.0-10.6 g
100-400 g ",V06DB
Enteral Nutrition - Modular,Oral:,"in 280-400 g Composed of:
Calories = 9.5-380 Kcal
Dilution = 0
Carbohydrates = 0.67-94 g
Protein = 5-23 g
Fat = 0.6 g
mOsm/kg = 900
Sodium = 15-110 mg
Potassium = 10-66 mg 
Phosphorus = 5-30 mg ",V06DB
Enteral Nutrition - Pediatric Polymeric,Oral:,"in 100 g composed of:
Calories = 445-511 Kcal
Dilution = 1:1
Carbohydrates = 14.9-62.2 g
Protein = 13.4-54.3 g
Fat = 16.2-26 g
mOsm/kg = 308-345
Sodium = 120-250 mg
Potassium = 400-750 mg 
Phosphorus = 150-760 mg ",V06DB
Enteral Nutrition - Semi-elemental,Oral:,"in 100 mL-1 L composed of:
Calories = 100-1300 Kcal
Dilution = 1:1-1:5:1
Carbohydrates = 13.8-172.2 g
Protein = 3.0-66.6 g
Fat = 3.9-37.4 g
mOsm/kg = 375-575
Sodium = 66-1040 mg
Potassium = 135-1730 mg 
Phosphorus = 22-867 mg
76-450 g ",V06DB
Eperisone hydrochloride,Oral:,50 mg Tablet ,M03BX09
Ephedrine,Inj.:,30 mg/mL Solution for injection in 1 mL Ampul ,R03CA02
Ephedrine,Inj.:,"50 mg/mL (as Sulfate) in 1 mL Ampul (IM,IV) ",R03CA02
Epinephrine (Adrenaline),Inj.:,"1 mg/mL (as Hydrochloride) in 1 mL Ampul (IV, IM, SC) *Primary Health Care",C01CA24
Epinephrine (Adrenaline),Inj.:,"0.3 mg in 0.3 mL Pre-loaded injection pen, auto-injector (IM preload) ",C01CA24
Epirubicin,Inj.:,10 mg (as Hydrochloride) Powder Vial (IV) ,L01DB03
Epirubicin,Inj.:,50 mg (as Hydrochloride) Powder Vial (IV) ,L01DB03
Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"2000 IU/0.5 mL Pre-filled syringe (IV,SC) ",B03XA01
Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"4000 IU/0.4 mL Pre-filled syringe (IV,SC) ",B03XA01
Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"4000 IU/mL in 1 mL Vial (IV,SC) ",B03XA01
Epoetin Alfa (Recombinant human erythropoietin),Inj.:,"10,000 IU/mL Pre-filled syringe (IV,SC) ",B03XA01
Epoetin Alfa (Recombinant Human Erythropoietin),IV/SC:,4000 IU/mL Solution for injection in 1 mL Pre-filled syringe ,B03XA01 
Epoetin Beta (Recombinant human erythropoietin),Inj.:,"2000 IU/0.3 mL Pre-filled syringe + needle (IV,SC) ",B03XA01
Epoetin Beta (Recombinant human erythropoietin),Inj.:,"5000 IU/0.3 mL Pre-filled syringe + needle (IV,SC) ",B03XA01
Epoetin Beta (Recombinant human erythropoietin),Inj.:,"10,000 IU/0.6 mL Pre-filled syringe (IV,SC) ",B03XA01
Ergotamine,Oral:,1 mg (as Tartrate) Tablet ,N02CA02
Ertapenem *Reserve antimicrobial,Inj.:,"1 g (as Sodium) Powder Vial (IM, IV) ",J01DH03
Erythromycin,Oral:,500 mg (as Stearate) Tablet *Primary Health Care,J01FA01
Erythromycin,Oral:,200 mg/5 mL (as Ethyl succinate) Granules/Powder for suspension in 60 mL *Primary Health Care,J01FA01
Erythromycin,Oral:,400 mg/5 mL (as Ethyl succinate) Granules/Powder for suspension in 50 mL ,J01FA01
Erythromycin,Oral:,400 mg/5 mL (as Ethyl succinate) Granules/Powder for suspension in 60 mL ,J01FA01
Erythromycin,Ophthalmic:,0.5% Ophthalmic ointment in 3.5 g Tube *Primary Health Care,J01FA01
Erythromycin,Ophthalmic:,0.5% Ophthalmic ointment in 5 g Tube ,J01FA01
Escitalopram,Oral:,10 mg (as Oxalate) Tablet *Primary Health Care,N06AB10
Esmolol,Inj.:,10 mg/mL (as Hydrochloride) in 10 mL Vial (IV) ,C07AB09
Esmolol,Inj.:,100 mg/mL (as Hydrochloride) in 10 mL Vial (IV) ,C07AB09
Ethambutol,Oral:,100 mg (as Hydrochloride) Tablet (Pediatric) ,J04AK02
Ethambutol,Oral:,200 mg (as Hydrochloride) Tablet *Primary Health Care,J04AK02
Ethambutol,Oral:,400 mg (as Hydrochloride) Tablet *Primary Health Care,J04AK02
Ethinylestradiol + Desogestrel,Oral:,30 mcg + 150 mcg Tablet ,G03AA09
Ethinylestradiol + Levonorgestrel,Oral:,30 mcg + 150 mcg Tablet *Primary Health Care,G03AA07
Ethinylestradiol + Norethisterone,Oral:,35 mcg + 400 mcg (as Acetate) Tablet ,G03AA05
Ethinylestradiol + Norgestrel,Oral:,30 mcg + 300 mcg Tablet ,G03AA06
Etonogestrel,Subdermal:,68 mg Implant ,G03AC08
Etoposide,Inj.:,20 mg/mL in 5 mL Ampul/Vial (IV) ,L01CB01
Etoposide,Inj.:,20 mg/mL in 10 mL Vial (IV) ,L01CB01
Etoposide,Inj.:,100 mg Powder Vial (IV) ,L01CB01
Everolimus,Oral:,250 mcg Tablet ,L01EG02
Everolimus,Oral:,500 mcg Tablet ,L01EG02
Factor IX Complex Concentrate,Inj.:,"100 IU/mL Lyophilized powder in 5 mL Vial (IV) (Coagulation Factors II, VII, IX, X) ",B02BD04
Factor IX Complex Concentrate,Inj.:,"100 IU/mL Lyophilized powder in 10 mL Vial (IV) (Coagulation Factors II, VII, IX, X) ",B02BD04
Factor IX Complex Concentrate,Inj.:,"500 IU Vial + Diluent (IV) (Coagulation Factors II, VII, IX, X) ",B02BD04
Factor VIII Concentrate,Inj.:,100 IU/g Lyophilized powder Vial + Diluent (IV) ,B02BD02
Famotidine,Oral:,20 mg Tablet ,A02BA03
Famotidine,Inj.:,20 mg Powder/Lyophilized powder for injection Ampul/Vial ,A02BA03
Felodipine,Oral:,5 mg Modified-release tablet ,C08CA02
Felodipine,Oral:,10 mg Modified-release tablet ,C08CA02
Fenofibrate,Oral:,200 mg Capsule *Primary Health Care,C10AB05
Fenofibrate,Oral:,160 mg Tablet *Primary Health Care,C10AB05
Fenofibrate,Oral:,200 mg Tablet *Primary Health Care,C10AB05 
Fentanyl,Oral:,100 mcg (as Citrate) Sublingual tablet ,N02AB03
Fentanyl,Oral:,200 mcg (as Citrate) Sublingual tablet ,N02AB03
Fentanyl,Oral:,300 mcg (as Citrate) Sublingual tablet ,N02AB03
Fentanyl,Oral:,400 mcg (as Citrate) Sublingual tablet ,N02AB03
Fentanyl,Inj.:,50 mcg/mL (as Citrate) in 2 mL Ampul (IV) ,N02AB03
Fentanyl,Inj.:,50 mcg/mL (as Citrate) in 10 mL Ampul (IV) ,N02AB03
Ferrous Salt,Oral:,"(equiv. to 60 mg elemental iron) Tablet 
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate, desicated = 32%) *Primary Health Care",B03AA07
Ferrous Salt,Oral:,"(equiv. to 15 mg elemental iron per 0.6 mL) Solution in 15 mL (Drops)
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate, desicated = 32%) *Primary Health Care",B03AA07
Ferrous Salt,Oral:,"(equiv. to 15 mg elemental iron per 0.6 mL) Solution in 30 mL (Drops)
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate , dessicated = 32%) *Primary Health Care",B03AA07
Ferrous Salt,Oral:,"(equiv. to 30 mg elemental iron per 5 mL) Solution 
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate , dessicated = 32%) *Primary Health Care",B03AA07
Ferrous Salt,Oral:,"Syrup in 60 mL 
(N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate = 33%
Ferrous gluconate = 12%
Ferrous lactate = 19%
Ferrous sulfate, hydrated = 20%
Ferrous sulfate , dessicated = 32%) *Primary Health Care",B03AA07
Ferrous Salt + Folic Acid,Oral:,60 mg (elemental iron) + 400 mcg Tablet/Capsule/Film-coated tablet *Primary Health Care,B03AD03
Filgrastim,IV/SC:,300 mcg/0.9 mL Solution in 0.9 mL Pre-filled syringe ,L03AA02 
Filgrasrim (G-CSF),Inj.:,"150 mcg/0.6 mL Vial (IV, SC) ",L03AA02
Filgrastim (G-CSF),Inj.:,"300 mcg/0.5 mL Solution for injection Pre-filled syringe (IV, SC) ",L03AA02
Filgrastim (G-CSF),Inj.:,"300 mcg/mL Vial (IV, SC) ",L03AA02
Filgrastim (G-CSF),Inj.:,"300 mcg/1.2 mL Vial (IV, SC) ",L03AA02
Finasteride,Oral:,5 mg Tablet *Primary Health Care,G04CB01
Fluconazole,Oral:,50 mg Capsule ,J02AC01
Fluconazole,Oral:,150 mg Capsule ,J02AC01
Fluconazole,Oral:,200 mg Capsule ,J02AC01
Fluconazole,Inj.:,2 mg/mL in 100 mL Vial (IV infusion) ,J02AC01
Flucytosine (5-fluoroyctosine),Oral:,250 mg Tablet ,J02AX01
Flumazenil,Inj.:,"100 mcg/mL in 5 mL Ampul (Slow IV, IV infusion) ",V03AB25
Flunarizine,Oral:,5 mg (as Hydrochloride) Capsule ,N07CA03
Fluocinonide,Topical:,0.05% Cream/Ointment in 5 g Tube ,D07AC08
Fluocinonide,Topical:,0.05% Cream/Ointment in 15 g Tube ,D07AC08
Fluorescein,Inj.:,10% (100 mg/mL) (as Sodium) in 5 mL Ampul (IV) ,S01JA01
Fluorescein,Ophthalmic:,1 mg (as Sodium) Strip ,S01JA01
Fluorescein,Ophthalmic:,9 mg (as Sodium) Strip ,S01JA01
Fluorouracil,Inj.:,50 mg/mL in 10 mL Ampul/Vial (IV) (IV infusion) ,L01BC02
Fluoxetine,Oral:,20 mg Dispersible tablet/Capsule *Primary Health Care,N06AB03
Flupentixol,Inj.:,20 mg/mL (as Decanoate) in 1 mL Ampul (IM) ,N05AF01
Flupentixol,Inj.:,20 mg/mL (as Decanoate) in 10 mL Vial (IM) ,N05AF01
Fluphenazine,Inj.:,25 mg/mL (as Decanoate) in 1 mL Ampul (IM) *Primary Health Care,N05AB02
Fluphenazine,Inj.:,25 mg/mL (as Decanoate) in 10 mL Vial (IM) *Primary Health Care,N05AB02
Flutamide,Oral:,250 mg Tablet ,L02BB01
Fluticasone,Inhalation:,"0.05% (as Propionate) per dose x 120 doses, Solution (Nasal aqueous solution) ",R03BA05
Fluticasone,Inhalation:,50 mcg/dose (as Propionate) DPI with appropriate accompanying dispenser ,R03BA05
Fluticasone,Inhalation:,250 mcg/dose (as Propionate) DPI with appropriate accompanying dispenser ,R03BA05
Fluticasone,Inhalation:,"50 mcg/dose (as Propionate) x 60 doses, MDI with appropriate accompanying dispenser ",R03BA05
Fluticasone,Inhalation:,"50 mcg/dose (as Propionate) x 120 doses, MDI with appropriate accompanying dispenser ",R03BA05
Fluticasone,Inhalation:,"125 mcg/dose (as Propionate) x 60 doses, MDI with appropriate accompanying dispenser ",R03BA05
Fluticasone,Inhalation:,"125 mcg/dose (as Propionate) x 120 doses, MDI with appropriate accompanying dispenser ",R03BA05
Fluticasone,Inhalation:,250 mcg/mL (as Propionate) in 2 mL (Unit dose) (For nebulization) ,R03BA05
Fluticasone + Formoterol,Inhalation:,"50 mcg (as Propionate) + 5 mcg (as Fumarate dihydrate) x 120 actuations, MDI ",R03AK11
Fluticasone + Formoterol,Inhalation:,"125 mcg (as Propionate) + 5 mcg (as Fumarate dihydrate) x 120 actuations, MDI ",R03AK11
Fluticasone + Formoterol,Inhalation:,"250 mcg (as Propionate) + 10 mcg (as Fumarate dihydrate) x 120 actuations, MDI ",R03AK11
Fluticasone + Salmeterol,Inhalation:,"100 mcg (as Propionate) + 50 mcg (as Xinafoate) x 28 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
Fluticasone + Salmeterol,Inhalation:,"100 mcg (as Propionate) + 50 mcg (as Xinafoate) x 60 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
Fluticasone + Salmeterol,Inhalation:,"250 mcg (as Propionate) + 50 mcg (as Xinafoate) x 28 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
Fluticasone + Salmeterol,Inhalation:,"250 mcg (as Propionate) + 50 mcg (as Xinafoate) x 60 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
Fluticasone + Salmeterol,Inhalation:,"500 mcg (as Propionate) + 50 mcg (as Xinafoate) x 28 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
Fluticasone + Salmeterol,Inhalation:,"500 mcg (as Propionate) + 50 mcg (as Xinafoate) x 60 doses, DPI with appropriate accompanying dispenser *Primary Health Care",R03AK06
Fluticasone + Salmeterol,Inhalation:,"50 mcg (as Propionate) + 25 mcg (as Xinafoate) x 120 actuations, MDI with dose counter ",R03AK06
Fluticasone + Salmeterol,Inhalation:,"125 mcg (as Propionate) + 25 mcg (as Xinafoate) x 120 actuations, MDI ",R03AK06
Fluticasone + Salmeterol,Inhalation:,"250 mcg (as Propionate) + 25 mcg (as Xinafoate) x 120 actuations, MDI ",R03AK06
Folic Acid,Oral:,400 mcg Tablet/Capsule *Primary Health Care,B03BB01
Folic Acid,Oral:,800 mcg Tablet/Capsule *Primary Health Care,B03BB01
Folic Acid,Oral:,1 mg Tablet/Capsule *Primary Health Care,B03BB01
Folic Acid,Oral:,5 mg Tablet/Capsule *Primary Health Care,B03BB01
Folic Acid,Oral:,2.5 mg/mL Syrup (Pediatric drops) *Primary Health Care,B03BB01
Folic Acid,Oral:,5 mg/5 mL Syrup *Primary Health Care,B03BB01
Fomepizole (4-methylprazole),Inj.:,1 g/mL in 1.5 mL Vial (IV) ,V03AB34
Fondaparinux,Inj.:,2.5 mg/0.5 mL (as Sodium) Solution ,B01AX05
Formoterol,Inhalation:,12 mcg DPI with appropriate accompanying dispenser ,R03AC13
Fosfomycin,Oral:,3 g Granules for Suspension ,J01XX01
Furosemide,Oral:,20 mg Tablet ,C03CA01
Furosemide,Oral:,40 mg Tablet *Primary Health Care,C03CA01
Furosemide,Inj.:,"10 mg/mL in 2 mL Ampul (IM, IV) *Primary Health Care",C03CA01
Furosemide,Inj.:,10 mg/mL in 25 mL Ampul (IV infusion) ,C03CA01
Fusidic Acid/Fusidate Sodium,Topical:,2% Cream in 5 g Tube *Primary Health Care,J01XC01
Fusidic Acid/Fusidate Sodium,Topical:,2% Ointment in 15 g Tube *Primary Health Care,J01XC01
Fusidic Acid/Fusidate Sodium,Ophthalmic:,1% (as Sulfate) Suspension in 5 g Tube (Eye drops) ,J01XC01
Gabapentin,Oral:,100 mg Capsule *Primary Health Care,N02BF01
Gabapentin,Oral:,300 mg Capsule *Primary Health Care,N02BF01
Gadobutrol,Inj.:,1 mmol/mL Solution for injection in 15 mL Vial ,V08CA09
Gadobutrol,Inj.:,1 mmol/mL Solution for injection in 5 mL Pre-filled syringe ,V08CA09
Gadoteric Acid,Inj.:,0.5 mmol/mL Solution for injection in 10 mL Vial ,V08CA02
Gadoteric Acid,Inj.:,0.5 mmol/mL Solution for injection in 15 mL Vial ,V08CA02
Gadoteric Acid,Inj.:,0.5 mmol/mL Solution for injection in 20 mL Vial ,V08CA02
Ganciclovir,Ophthalmic:,0.15% Gel in 5 g Tube ,J05AB06
Ganciclovir,Inj.:,500 mg (as Sodium) Vial (IV infusion) ,J05AB06
Gemcitabine,Inj.:,200 mg (as Hydrochloride) Vial (IV infusion) ,L01BC05
Gemcitabine,Inj.:,1 g (as Hydrochloride) Vial (IV infusion) ,L01BC05
Gentamicin,Inj.:,"10 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) *Primary Health Care",J01GB03
Gentamicin,Inj.:,"40 mg/mL (as Sulfate) in 2 mL Ampul/Vial (IM, IV) *Primary Health Care",J01GB03
Gliclazide,Oral:,30 mg Modified Release (MR) tablet *Primary Health Care,A10BB09
Gliclazide,Oral:,60 mg Modified Release (MR) tablet ,A10BB09
Gliclazide,Oral:,80 mg Tablet *Primary Health Care,A10BB09
Glucagon,Inj.:,"1 mg (as Hydrochloride) Lyophilized powder + Solvent (IM, IV, SC) ",H04AA01
Glucose (Dextrose),Inj.:,50% in 50 mL Vial (IV) *Primary Health Care,V06DC01
Glucose (Dextrose),Inj.:,50% in 10 mL Ampul (IV) ,V06DC01
Glucose (Dextrose),Inj.:,50% in 20 mL Ampul (IV) ,V06DC01
Glucose (Dextrose),Inj.:,50% in 10 mL Vial (IV)(85 Kcal) ,V06DC01
Glucose (Dextrose),Inj.:,50% in 20 mL Vial (IV)(85 Kcal) ,V06DC01
Glucose (Dextrose),Inj.:,50% in 50 mL Vial (IV)(85 Kcal) ,V06DC01
Glycerin (Glycerol),Oral:,USP Grade (Liquid) ,A06AG04
Glycerin (Glycerol),Rectal:,2 g Suppository ,A06AG04
Glycerin (Glycerol),Rectal:,2.5 g Suppository ,A06AG04
Glyceryl trinitrate (Nitroglycerin),Inj.:,1 mg/mL in 10 mL Ampul (IV infusion) ,C01DA02
Glyceryl trinitrate (Nitroglycerin),Inj.:,1 mg/mL in 25 mL Ampul (IV infusion) ,C01DA02
Goserelin,Inj.:,3.6 mg (as Acetate) Depot solution Pre-filled syringe (SC) ,L02AE03
Goserelin,Inj.:,10.8 mg (as Acetate) Depot solution Pre-filled syringe (SC) ,L02AE03
Haloperidol,Oral:,2 mg Tablet *Primary Health Care,N05AD01
Haloperidol,Oral:,5 mg Tablet *Primary Health Care,N05AD01
Haloperidol,Oral:,10 mg Tablet *Primary Health Care,N05AD01
Haloperidol,Inj.:,5 mg/mL in 1 mL Ampul (IM) *Primary Health Care,N05AD01
Haloperidol,Inj.:,50 mg/mL (as Decanoate) in 1 mL Ampul (IM)(Oily) *Primary Health Care,N05AD01
Halothane,Inhalation:,in 250 mL Bottle ,N01AB01
Hemophilus Influenzae type B Conjugated (Hib) Vaccine,Inj.:,10 mcg/0.5 mL in 1 Dose vial + 0.5 mL diluent with tetanus protein (IM) *Primary Health Care,J07AG01 
Hemophilus Influenzae type B Conjugated (Hib) Vaccine,Inj.:,10 mcg/0.5 mL Vial + 0.9% sodium chloride with diptheria CRM 197 protein (IM) *Primary Health Care,J07AG01 
Hemophilus Influenzae type B Conjugated (Hib) Vaccine,Inj.:,in 0.5 mL Vial + Meningococcal protein (IM) *Primary Health Care,J07AG01 
Heparin,Inj.:,"1000 IU/mL (as Sodium) in 5 mL Vial (IV infusion, SC) (Bovine origin) (Unfractionated) ",C05BA03
Heparin,Inj.:,"5000 IU/mL (as Sodium) in 5 mL Vial (IV infusion, SC) (Bovine origin) (Unfractionated) ",C05BA03
Hepatitis A Inactivated Vaccine,Inj.:,Viral antigen not less than 720 EU  in 0.5 mL Monodose vial (IM) (Junior) ,J07BC02
Hepatitis A Inactivated Vaccine,Inj.:,Viral antigen not less than 1440 EU  in 1 mL Monodose vial (IM) (Adult) ,J07BC02
Hepatitis A Inactivated Vaccine,Inj.:,80 units/0.5 mL Pre-filled syringe (IM) (Pediatric) (Single dose) (GBM strain) ,J07BC02
Hepatitis A Inactivated Vaccine,Inj.:,160 units/0.5 mL Pre-filled syringe (IM) (Pediatric) (Single dose) (GBM strain) ,J07BC02
Hepatitis B Immunoglobulin,Inj.:,in 0.5 mL Vial (IM) (Human) ,J06BB04
Hepatitis B Immunoglobulin,Inj.:,in 1 mL Vial (IM) (Human) ,J06BB04
Hepatitis B Immunoglobulin,Inj.:,in 2 mL Vial (IM) (Human) ,J06BB04
Hepatitis B Vaccine,Inj.:,"10 mcg/0.5 mL Monodose vial (IM) (Pediatric) (Recombinant DNA)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
Hepatitis B Vaccine,Inj.:,"10 mcg/0.5 mL x 10 dose, in 5 mL Vial (IM) (Recombinant DNA)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
Hepatitis B Vaccine,Inj.:,"20 mcg/mL Monodose vial (IM) (Adult) (Recombinant DNA) (For more than 10 years old)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
Hepatitis B Vaccine,Inj.:,"20 mcg/mL x 10 dose, in 10 mL Vial (IM) (Adult) (Recombinant DNA)
(N.B.: Formulations of different manufacturers are of equal or similar immunogenicity. Follow strictly the recommended dose of each manufacturer) *Primary Health Care",J07BC01
Human Papillomavirus Vaccine,Inj.:,"Suspension in 0.5 mL Glass pre-filled syringe (IM) (Quadrivalent - Types 6, 11, 16, 18) (Recombinant) ",J07BM03
Human Papillomavirus Vaccine,Inj.:,"in 0.5 mL Glass vial (IM) (Quadrivalent - Types 6, 11, 16, 18) (Recombinant) ",J07BM03
Human Papillomavirus Vaccine,Inj.:,"Suspension in 0.5 mL Pre-filled syringe (Type 1 glass) with plunger stopper (rubber butyl) and sterile needle (Types 16 and 18) (Recombinant, AS04 Adjuvanted) ",J07BM03
Human Papillomavirus Vaccine,Inj.:,"0.5 mL in 3 mL Monodose vial (Type 1 glass) (Types 16 and 18) (Recombinant, AS04 Adjuvanted) ",J07BM03
Human Papillomavirus Vaccine,Inj.:,"1 mL in 3 mL Glass vial (Types 16 and 18) (Recombinant, AS04 Adjuvanted) ",J07BM03
Hydralazine,Oral:,25 mg (as Hydrochloride) Tablet ,C02DB02
Hydralazine,Oral:,50 mg (as Hydrochloride) Tablet ,C02DB02
Hydralazine,Inj.:,"20 mg/mL (as Hydrochloride) in 1 mL Ampul (IM, IV) *Primary Health Care",C02DB02
Hydrochlorothiazide,Oral:,12.5 mg Tablet *Primary Health Care,C03AA03
Hydrochlorothiazide,Oral:,25 mg Tablet *Primary Health Care,C03AA03
Hydrocortisone,Oral:,5 mg Tablet *Primary Health Care,D07AA02
Hydrocortisone,Oral:,20 mg Tablet *Primary Health Care,D07AA02
Hydrocortisone,Inj.:,"50 mg/mL (as Sodium succinate) in 2 mL Vial (IM, IV) *Primary Health Care",D07AA02
Hydrocortisone,Inj.:,125 mg/mL (as Sodium succinate) in 2 mL Vial (IV) *Primary Health Care,D07AA02
Hydrocortisone,Inj.:,100 mg (as Sodium succinate) Powder Vial (IV) *Primary Health Care,D07AA02
Hydrocortisone,Inj.:,250 mg (as Sodium succinate) Powder Vial (IV) *Primary Health Care,D07AA02
Hydrocortisone,Topical:,1% Cream/Ointment in 5 g Tube *Primary Health Care,D07AA02
Hydrocortisone,Topical:,1% Cream/Ointment in 10 g Tube ,D07AA02
Hydrocortisone,Topical:,1% Lotion in 25 mL Bottle ,D07AA02
Hydrocortisone,Topical:,2.5% Lotion in 25 mL Bottle ,D07AA02
Hydrocortisone,Inj.:,125 mg/mL (as Sodium succinate) in 4 mL Vial (IV) *Primary Health Care,H02AB09 
Hydrogen Peroxide,Topical:,3% Solution in 60 mL ,D11AX25
Hydrogen Peroxide,Topical:,3% Solution in 120 mL *Primary Health Care,D11AX25
Hydroxychloroquine,Oral:,200 mg (as Sulfate) Tablet ,P01BA02
Hydroxyethyl Starch,Inj.:,6%  Solution in 250 mL Bottle (IV infusion) ,B05AA07
Hydroxyethyl Starch,Inj.:,6% Solution in 500 mL Bottle (IV infusion) ,B05AA07
Hydroxyurea,Oral:,500 mg Capsule ,L01XX05
Hydroxyzine,Oral:,25 mg (as Dihydrochloride) Tablet ,N05BB01
Hydroxyzine,Oral:,2 mg/mL (as Dihydrochloride) Syrup in 100 mL ,N05BB01
Hyoscine ,Oral:,10 mg (as N-butyl bromide) Tablet *Primary Health Care,A03BA03
Hyoscine ,Oral:,5 mg/5 mL (as N-butyl bromide) Syrup in 60 mL *Primary Health Care,A03BA03
Hyoscine ,Inj.:,"20 mg/mL (as N-butyl bromide) in 1 mL Ampul (IM, IV, SC) *Primary Health Care",A03BA03
Hypertonic lactate,Inj.:,"Solution for IV infusion in 250 mL containing:

Sodium Lactate Solution (50%) = 28.250 g (equal with 14.125 Solution Lactate)
Potassium Chloride = 0.075 g
Calcium Chloride 2H20 (100%) = 0.05 g
Water for injection = q.s.

Composed of:
Na+ = 504.15 mmol/L
K+ = 40.2 mmol/L
Ca++ = 1.36 mmol/L
Cl- = 6.74 mmol/L
Lactate = 504.15 mmol/L ",Not available
Hypertonic Saline Solution ,,3% (For diagnosis of pulmonary tuberculosis) ,Not available
Hypromellose,Ophthalmic:,5 mg/mL Solution in 10 mL (Eye drops) ,S01KA02
Hypromellose,Ophthalmic:,5 mg/mL Solution in 15 mL (Eye drops) ,S01KA02
Hypromellose,Ophthalmic:,10 mg/mL Solution in 10 mL (Eye drops) ,S01KA02
Hypromellose,Ophthalmic:,10 mg/mL Solution in 15 mL (Eye drops) ,S01KA02
Hypromellose,Ophthalmic:,0.3% Solution in 10 mL Bottle ,S01KA02
Ibuprofen,Oral:,200 mg Capsule *Primary Health Care,M01AE01
Ibuprofen,Oral:,400 mg Capsule *Primary Health Care,M01AE01
Ibuprofen,Oral:,100 mg/5 mL Syrup/Suspension in 60 mL *Primary Health Care,M01AE01
Ibuprofen,Oral:,200 mg/5 mL Suspension in 60 mL ,M01AE01
Idarubicin,Inj.:,5 mg (as Hydrochloride) Powder Vial (IV) ,L01DB06
Ifosfamide,Inj.:,1 g Powder Vial (IV Infusion) ,L01AA06
Ifosfamide,Inj.:,2 g Powder Vial (IV Infusion) ,L01AA06
Imatinib,Inj.:,100 mg (as Mesilate) Tablet ,L01EA01
Imatinib,Inj.:,400 mg (as Mesilate) Tablet ,L01EA01
Imiglucerase,Inj.:,400 IU Powder in 20 mL Vial (IV Infusion) ,A16AB02
Imiquinod,Topical:,5% Cream Aluminum foil sachet ,D06BB10
"Immunoglobulin Normal, Human (IGIM)",Inj.:,160 mg/mL in 2 mL Vial (IM) ,J06BA01
"Immunoglobulin Normal, Human (IGIM)",Inj.:,160 mg/mL in 5 mL Vial (IM) ,J06BA01
"Immunoglobulin Normal, Human (IGIM)",Inj.:,160 mg/mL in 10 mL Vial (IM) ,J06BA01
"Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 10 mL Vial (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 20 mL Vial (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 50 mL Vial (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 100 mL Vial (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,50 mg/mL in 200 mL Vial (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 1 g Bottle + 33 mL reconstitution fluid (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 1 g Bottle + 50 mL reconstitution fluid (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 2.5 g Bottle + 100 mL reconstitution fluid (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 5 g Bottle + 100 mL diluent vial (IV) ,J06BA02
"Immunoglobulin Normal, Human (IGIV)",Inj.:,Freeze-dried powder in 10 g Bottle + 260 mL diluent vial (IV) ,J06BA02
Inactivated Polio Vaccine,Inj.:,"0.5 mL/dose Suspension for injection in 5 mL Multidose vial (IM, SC) (Types 1, 2, and 3) ",J07CA02
Inactivated Poliomyelitis Vaccine,Inj.:,"0.5 mL/dose Suspension for injection Single dose/multidose vial (IM, SC) (Types 1, 2, and 3) *Primary Health Care",J07BF01
Indacaterol + Glycopyrronium,Inhalation:,110 mcg (as Maleate) + 50 mcg (as Bromide) Powder in hard capsules ,R03AL12
Indapamide,Oral:,1.5 mg Modified Release (MR) tablet ,C03BA11
Influenza Polyvalent Vaccine,Inj.:,"in 0.5 mL Vial + Pre-filled syringe diluent (IM)
(N.B.: Strains as recommended by WHO) *Primary Health Care",J07BB02
Influenza Polyvalent Vaccine,Inj.:,"Suspension in 0.5 mL Pre-filled syringe/ampule (IM) (Adult)
(N.B.: Strains as recommended by WHO) *Primary Health Care",J07BB02
Influenza Polyvalent Vaccine,Inj.:,"15 mcg/0.5 mL in 5 mL Multidose vial 
(N.B.: Strains as recommended by WHO) *Primary Health Care",J07BB02
Influenza Polyvalent Vaccine,Inj.:,"7.5 mcg/ 0.25 mL Suspension for injection in 0.25 mL Single dose pre-filled glass syringe 
(N.B.: Strains as recommended by WHO) ",J07BB02
Insulin Glargine,SC:,100 IU/mL in 10 mL Vial ,A10AE04 
Insulin Glargine,SC:,100 IU/mL in 3 mL Pre-filled pen ,A10AE04 
Interferon Alfa 2B,Inj.:,"3 million IU/mL Vial + Diluent (IM, SC) (Human) ",L03AB05
Interferon Alfa 2B,Inj.:,"5 million IU/mL Vial + Diluent (IM, SC) (Human) ",L03AB05
Intraocular Irrigation Solution (Balanced salt solution),Intraocular:,"in 15 mL composed of:
Sodium chloride = 0.64%
Potassium chloride = 0.075%
Calcium chloride = 0.048%
Magnesium chloride hexahydrate = 0.03%
Sodium acetate = 0.39%
Sodium citrate = 0.17%
Water for injection to make 100% ",B05CX10
Intraocular Irrigation Solution (Balanced salt solution),Intraocular:,"in 250 mL composed of:
Sodium chloride = 0.64%
Potassium chloride = 0.075%
Calcium chloride = 0.048%
Magnesium chloride hexahydrate = 0.03%
Sodium acetate = 0.39%
Sodium citrate = 0.17%
Water for injection to make 100% ",B05CX10
Intraocular Irrigation Solution (Balanced salt solution),Intraocular:,"in 500 mL composed of:
Sodium chloride = 0.64%
Potassium chloride = 0.075%
Calcium chloride = 0.048%
Magnesium chloride hexahydrate = 0.03%
Sodium acetate = 0.39%
Sodium citrate = 0.17%
Water for injection to make 100% ",B05CX10
Iodine,Topical:,1% Tincture ,H03C
Iodine,Topical:,2% Tincture ,H03C
Iodine,Topical:,2% Solution ,H03C
Iodine,Topical:,5% Solution ,H03C
Iodine + Potassium iodide (Lugol's Solution),Oral:,"5% + 10% Solution in 30 mL (Aqueous iodine solution, total iodine = 130 mg/mL) ",H03C
Iodixanol,Inj.:,652 mg/mL (equiv. to 320 mg iodine) Solution in 50 mL Vial ,V08AB09
Iodixanol,Inj.:,652 mg/mL (equiv. to 320 mg iodine) Solution in 100 mL Vial ,V08AB09
Iodixanol,Inj.:,550 mg/mL (equiv. to 270 mg iodine) Solution in 50 mL Vial ,V08AB09
Iodized Oil Fluid,Oral:,500 mg (equiv. to 200 mg elemental iodine) Softgel capsule (Only for DOH program) ,Not available
Iohexol,Inj.:,300 mg iodine/mL in 50 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
Iohexol,Inj.:,300 mg iodine/mL in 100 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
Iohexol,Inj.:,350 mg iodine/mL in 50 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
Iohexol,Inj.:,350 mg iodine/mL in 100 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB02
Iopamidol,Inj.:,612 mg/mL (equiv. to 300 mg iodine) in 50 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB04
Iopamidol,Inj.:,612 mg/mL (equiv. to 300 mg iodine) in 100 mL Vial (Intravascular and other parenteral routes as appropriate) ,V08AB04
Iopamidol,Inj.:,755 mg/mL (equiv. to 370 mg iodine) in 50 mL Vial/bottle (Intravascular and other parenteral routes as appropriate) ,V08AB04
Iopamidol,Inj.:,755 mg/mL (equiv. to 370 mg iodine) in 100 mL Vial/bottle (Intravascular and other parenteral routes as appropriate) ,V08AB04
Iopromide,Inj.:,300 mg/mL (equiv. to 623 mg iodine) in 50 mL Vial ,V08AB05
Iopromide,Inj.:,300 mg/mL (equiv. to 623 mg iodine) in 100 mL Vial ,V08AB05
Iopromide,Inj.:,370 mg/mL (equiv. to 769 mg iodine) in 50 mL Vial ,V08AB05
Iopromide,Inj.:,370 mg/mL (equiv. to 769 mg iodine) in 100 mL Vial ,V08AB05
Iothalamate,Inj.:,600 mg /mL (as Meglumine) in 30 mL Vial (Usually IV) ,V09CX03
Iothalamate,Inj.:,600 mg /mL (as Meglumine) in 50 mL Vial (Usually IV) ,V09CX03
Iothalamate,Inj.:,600 mg /mL (as Meglumine) in 100 mL Vial (Usually IV) ,V09CX03
Ioversol,Inj.:,636 mg/mL (equiv. to 300 mg/mL iodine) in 50 mL Vial ,V08AB07
Ioversol,Inj.:,636 mg/mL (equiv. to 300 mg/mL iodine) in 100 mL Vial ,V08AB07
Ioversol,Inj.:,741 mg/mL (equiv. to 350 mg/mL iodine) in 50 mL Vial ,V08AB07
Ioversol,Inj.:,741 mg/mL (equiv. to 350 mg/mL iodine) in 100 mL Vial ,V08AB07
Ipratropium,Inhalation:,"20 mcg/dose (as Bromide) x 200 doses, MDI *Primary Health Care",R03BB01
Ipratropium,Inhalation:,250 mcg/mL (as Bromide) Respiratory solution in 2 mL Unit dose (For nebulization) *Primary Health Care,R03BB01
Ipratropium + Fenoterol,Inhalation:,"20 mcg (as Bromide) + 50 mcg (as Hydrobromide) x 10 mL doses, MDI ",R03AL01
Ipratropium + Salbutamol,Inhalation:,"20 mcg (as Bromide) + 100 mcg x 200 doses, in 10 mL MDI *Primary Health Care",R03AL02
Ipratropium + Salbutamol,Inhalation:,500 mcg (as Bromide anhydrous) + 2.5 mg (as Base) in 2.5 mL Unit dose (For nebulization) *Primary Health Care,R03AL02
Irbesartan,Oral:,150 mg Tablet ,C09CA04
Irbesartan,Oral:,300 mg Tablet ,C09CA04
Irbesartan + Hydrochlorothiazide,Oral:,150 mg + 12.5 mg Tablet ,C09DX07
Irinotecan,Inj.:,40 mg/2 mL (as Hydrochloride) Vial (IV infusion) ,L01CE02
Irinotecan,Inj.:,100 mg/5 mL (as Hydrochloride) Vial (IV infusion) ,L01CE02
Iron sucrose,Inj.:,20 mg/mL in 5 mL Ampul ,B03AE04
Isoflurane,Inhalation:,in 100 mL Bottle ,N01AB06
Isoflurane,Inhalation:,in 250 mL Bottle ,N01AB06
Isoniazid,Oral:,300 mg Tablet *Primary Health Care,J04AC01
Isoniazid,Oral:,400 mg Tablet *Primary Health Care,J04AC01
Isoniazid,Oral:,200 mg/5 mL Syrup in 120 mL *Primary Health Care,J04AC01
Isoniazid + Rifampicin,Oral:,50 mg + 75 mg Dispersible tablet (Fixed dose combination) (Pediatric) ,J04AM05
Isoniazid + Rifampicin,Oral:,75 mg + 150 mg Tablet *Primary Health Care,J04AM05
Isoniazid + Rifampicin + Ethambutol,Oral:,75 mg + 150 mg + 275 mg Tablet *Primary Health Care,J04AM06
Isoniazid + Rifampicin + Pyrazinamide,Oral:,50 mg + 75 mg + 150 mg Dispersible tablet (Fixed dose combination) (Pediatric) ,J04AM06
Isoniazid + Rifampicin + Pyrazinamide + Ethambutol,Oral:,75 mg + 150 mg + 400 mg + 275 mg Tablet *Primary Health Care,J04AM06
Isophane Insulin Human,Inj.:,100 IU/mL in 3 mL Pre-filled syringe (SC) (Recombinant DNA) *Primary Health Care,A10AB30
Isophane Insulin Human,Inj.:,100 IU/mL in 5 mL Vial (SC) (Recombinant DNA) *Primary Health Care,A10AB30
Isophane Insulin Human,Inj.:,100 IU/mL in 10 mL Vial (SC) (Recombinant DNA) *Primary Health Care,A10AB30
Isosorbide,Oral:,10 mg (as Dinitrate) Tablet *Primary Health Care,C01DA08
Isosorbide,Oral:,20 mg (as Dinitrate) Tablet *Primary Health Care,C01DA08
Isosorbide,Oral:,20 mg (as Dinitrate) Modified Release (MR) tablet/Capsule *Primary Health Care,C01DA08
Isosorbide,Sublingual:,5 mg (as Dinitrate) Sublingual (SL) tablet *Primary Health Care,C01DA08
Isosorbide,Inj.:,1 mg/mL (as Dinitrate) in 10 mL Ampul (IV) ,C01DA08
Isosorbide,Oral:,40 mg (as 5-Mononitrate) Tablet ,C01DA08
Isosorbide,Oral:,30 mg (as 5-Mononitrate) Modified Release (MR) tablet/Capsule *Primary Health Care,C01DA08
Isosorbide,Oral:,60 mg (as 5-Mononitrate) Modified Release (MR) tablet/Capsule *Primary Health Care,C01DA08
Isotonic electrolyte solution for IV infusion,Inj.:,"in 1 L composed of:
Sodium chloride = 6.80 g
Potassium chloride = 0.30 g
Calcium chloride dihydrate = 0.37 g
Magnesium chloride hexahydrate = 0.20 g
Sodium acetate trihydrate = 3.27 g
Malic acid = 0.67 g ",B05BB01
Isoxsuprine,Oral:,10 mg (as Hydrochloride) Tablet ,C04AA01
Isoxsuprine,Oral:,40 mg (as Hydrochloride) Tablet ,C04AA01
Isoxsuprine,Inj.:,"5 mg/mL (as Hydrochloride) in 2 mL Ampul (IM, IV infusion) ",C04AA01
Itraconazole,Oral:,100 mg Capsule ,J02AC02
Ivermectin,Oral:,3 mg Tablet ,P02CF01
Ivermectin,Oral:,6 mg Tablet ,P02CF01
Kanamycin,Inj.:,1 g (as Sulfate) Vial (IM) ,J01GB04
Ketamine,Inj.:,"50 mg/mL (as Hydrochloride) Vial (IM, IV) ",N01AX03
Ketoconazole,Topical:,2% (20 mg/g) Cream in 3.5 g Aluminum collapsible tube ,J02AB02 
Ketoconazole,Topical:,2% (20 mg/g) Cream in 15 g Aluminum collapsible tube ,J02AB02 
Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 6 mL Foil sachet *Primary Health Care,J02AB02 
Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 10 mL Bottle *Primary Health Care,J02AB02 
Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 60 mL Bottle *Primary Health Care,J02AB02 
Ketoconazole,Topical:,2% (20 mg/g) Shampoo in 100 mL Bottle *Primary Health Care,J02AB02 
Ketoprofen,Oral:,100 mg Tablet ,M02AA10
Ketoprofen,Inj.:,50 mg/mL in 2 mL Ampul (IM) ,M02AA10
Ketorolac,Inj.:,"30 mg/mL (as Tromethamol) in 1 mL Ampul (IM, IV) ",S01BC05
Lactated Ringer's solution (Ringer's Lactate),Inj.:,"in 500 mL Bottle/Bag (IV infusion) composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22 - 1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",B05XA30
Lactated Ringer's solution (Ringer's Lactate),Inj.:,"in 1 L Bottle/Bag (IV infusion) composed of:
Na+ = 130 mmol/L
K+ = 4 mmol/L
Ca++ = 1.22 - 1.5 mmol/L
Cl- = 109 mmol/L
Lactate = 28 mmol/L *Primary Health Care",B05XA30
Lactulose,Oral:,3.3 g/5 mL (3.35 g/5 mL) Syrup *Primary Health Care,A06AD11
Lactulose,Oral:,3.3 g/5 mL (3.35 g/ 5 mL) Syrup in 120 mL *Primary Health Care,A06AD11 
Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,300 mg Tablet *Primary Health Care,Not Available
Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,600 mg Tablet *Primary Health Care,Not Available
Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,300 mg/5 mL Syrup in 60 mL *Primary Health Care,Not Available
Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,300 mg/5 mL Syrup in 120 mL *Primary Health Care,Not Available
Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,600 mg/5 mL Syrup in 60 mL ,Not Available
Lagundi (Vitex negundo L. [Fam. Verbenaceae]),Oral:,600 mg/5 mL Syrup in 120 mL ,Not Available
Lamivudine,Oral:,100 mg Tablet/Film-coated tablet ,J05AF05
Lamivudine,Oral:,150 mg Tablet/Film-coated tablet ,J05AF05
Lamivudine,Oral:,10 mg/mL Suspension in 240 mL Bottle ,J05AF05
Lamivudine + Efavirenz + Tenofovir,Oral:,300 mg + 600 mg + 300 mg Tablet ,J05AR11
Lamivudine + Tenofovir,Oral:,300 mg + 300 mg Tablet ,J05AR12
Lamivudine + Zidovudine,Oral:,150 mg + 300 mg Tablet ,J05AR01
Lamivudine + Zidovudine + Nevirapine,Oral:,150 mg + 300 mg + 200 mg Tablet ,J05AR05
Lamotrigine,Oral:,50 mg Tablet ,N03AX09
Lamotrigine,Oral:,100 mg Tablet ,N03AX09
Lansoprazole,Oral:,15 mg Capsule ,A02BC03
Lansoprazole,Oral:,30 mg Capsule ,A02BC03
Lansoprazole,Oral:,15 mg Modified Release (MR) tablet ,A02BC03
Lansoprazole,Oral:,30 mg Modified Release (MR) tablet ,A02BC03
Latanoprost,Ophthalmic:,50 mcg/mL Solution in 2.5 mL (Eye drops) ,S01EE01
Latanoprost + Timolol,Ophthalmic:,50 mcg + 5 mcg/mL (as Maleate) Solution in 5 mL Bottle (Eye drops) ,S01ED51
Letrozole,Oral:,2.5 mg Tablet/Film-coated tablet ,L02BG04
Leuproreline,Inj.:,"3.75 mg/2 mL (as Acetate) Vial + Syringe (IM, SC) ",L02AE02
Leuproreline,Inj.:,"1.88 mg (as Acetate) Single dose, Powder + Syringe (IM, SC) ",L02AE02
Leuproreline,Inj.:,"3.75 mg (as Acetate) Single dose, Powder + Syringe (IM, SC) ",L02AE02
Leuproreline,Inj.:,"11.25 mg (as Acetate) Depot solution Vial + Syringe (IM, SC) ",L02AE02
Leuproreline,Inj.:,7.5 mg (as Acetate) Pre-filled syringe (SC) ,L02AE02
Leuproreline,Inj.:,22.5 mg (as Acetate) Pre-filled syringe (SC) ,L02AE02
Leuproreline,Inj.:,45 mg (as Acetate) Pre-filled syringe (SC) ,L02AE02
Levetiracetam,Oral:,250 mg Film-coated tablet ,N03AX14 
Levetiracetam,Oral:,500 mg Film-coated tablet ,N03AX14 
Levetiracetam,Oral:,750 mg Film-coated tablet ,N03AX14 
Levetiracetam,Oral:,1 g Film-coated tablet ,N03AX14 
Levetiracetam,Inj.:,500 mg/5 mL (100 mg/mL) Solution in 5 mL Vial (IV infusion) (Concentrate) ,N03AX14 
Levetiracetam,Oral:,100 mg/mL Solution in 100 mL Bottle ,N03AX14 
Levetiracetam,Oral:,100 mg/mL Solution in 300 mL Bottle ,N03AX14 
Levobupivacaine,Inj.:,5 mg/mL Solution in 10 mL Ampul ,N01BB10
Levodopa + Carbidopa,Oral:,100 mg + 25 mg Tablet *Primary Health Care,N04BA02
Levodopa + Carbidopa,Oral:,250 mg + 25 mg Tablet *Primary Health Care,N04BA02
Levodopa + Carbidopa,Oral:,200 mg + 50 mg Extended Release (ER) tablet *Primary Health Care,N04BA02
Levofloxacin,Oral:,250 mg Tablet ,J01MA12 
Levofloxacin,Oral:,500 mg Tablet ,J01MA12 
Levofloxacin,Oral:,750 mg Tablet ,J01MA12 
Levofloxacin,Inj.:,5 mg/mL Solution in 100 mL Vial (IV infusion) ,J01MA12 
Levofloxacin,Inj.:,5 mg/mL Solution in 150 mL Vial (IV infusion) ,J01MA12 
Levofloxacin,Ophthalmic:,5 mg/mL (0.5% w/v) Solution (Eye drops) ,J01MA12 
Levothyroxine,Oral:,50 mcg (as Sodium/anhydrous Sodium) Tablet *Primary Health Care,H03AA01
Levothyroxine,Oral:,100 mcg (as Sodium/anhydrous Sodium) Tablet *Primary Health Care,H03AA01
Levothyroxine,Oral:,150 mcg (as Sodium/anhydrous Sodium) Tablet *Primary Health Care,H03AA01
Lidocaine,Inj.:,1% (as Hydrochloride) in 20 mL Ampul *Primary Health Care,C01BB01
Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 2 mL Ampul/vial (IM, IV) ",C01BB01
Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 5 mL Ampul/vial (IM, IV) ",C01BB01
Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 20 mL Ampul/vial (IM, IV) ",C01BB01
Lidocaine,Inj.:,"2% (20 mg/mL) (as Hydrochloride) in 50 mL Ampul/vial (IM, IV) ",C01BB01
Lidocaine,Inj.:,"2% (as Hydrochloride) in 5 mL Vial (Epidural, local infiltration) *Primary Health Care",C01BB01
Lidocaine,Inj.:,"2% (as Hydrochloride) in 50 mL Vial (Epidural, local infiltration) *Primary Health Care",C01BB01
Lidocaine,Inj.:,2% (as Hydrochloride) in 1.8 mL Carpule + Epinephrine (local infiltration) *Primary Health Care,C01BB01
Lidocaine,Topical:,10% (as Hydrochloride) Solution in 50 mL Spray *Primary Health Care,C01BB01
Linezolid *Reserve antimicrobial,Oral:,600 mg Tablet/Film-coated tablet ,J01XX08
Linezolid *Reserve antimicrobial,Inj.:,2 mg/mL (600 mg/300 mL) Solution for IV infusion ,J01XX08
Lipids,Inj.:,10% in 100 mL Bottle (IV infusion) ,C10BX 
Lipids,Inj.:,10% in 200 mL Bottle (IV infusion) ,C10BX 
Lipids,Inj.:,10% in 500 mL Bottle (IV infusion) ,C10BX 
Lipids,Inj.:,20% in 100 mL Bottle (IV infusion) ,C10BX 
Lipids,Inj.:,20% in 250 mL Bottle (IV infusion) ,C10BX 
Lipids,Inj.:,20% in 500 mL Bottle (IV infusion) ,C10BX 
Lithium ,Oral:,450 mg (as Carbonate) Modified Release (MR) tablet *Primary Health Care,N05AN01
Live Attenuated Bivalent Oral Polio Vaccine,Oral:,"2 mg 20 doses, in Vial (Types 1 and 3) *Primary Health Care",J07BF02
Live Attenuated Measles and Rubella (MR) Vaccine,Inj.:,"x 10 doses/vial, Multidose vial + 5 mL diluent (SC)(With vaccine vial monitor) ",J07BD53
Live Attenuated Measles Vaccine,Inj.:,Monodose vial + 0.5 mL diluent (SC) *Primary Health Care,J07BD01
Live Attenuated Measles Vaccine,Inj.:,Multidose vial + 5 mL diluent (SC) *Primary Health Care,J07BD01
"Live Attenuated Measles, Mumps and Rubella (MMR) Vaccine",Inj.:,Monodose vial + 0.5 mL diluent (SC) *Primary Health Care,J07BD52
"Live Attenuated Measles, Mumps and Rubella (MMR) Vaccine",Inj.:,Multidose vial + 5 mL diluent (SC) *Primary Health Care,J07BD52
Live Attenuated Mumps Vaccine,Inj.:,Monodose vial + 0.5 mL diluent (SC) ,J07BE01
Live Attenuated Rubella Vaccine,Inj.:,Monodose vial + 0.5 mL diluent (SC) ,J07BJ01
Live Attenuated Rubella Vaccine,Inj.:,Multidose vial + 5 mL diluent (SC) ,J07BJ01
Live Attenuated Varicella Vaccine,Inj.:,Not less than 2000 PFU Freeze-dried powder Monodose vial + 0.5 mL water for injection ampule) (SC only)(OKA strain varicella zoster virus) ,J07BK01
Loperamide,Oral:,2 mg (as Hydrochloride) Capsule (N.B.: Not for infants and children less than 12 years old) *Primary Health Care,A07DA03
Lopinavir + Ritonavir,Oral:,200 mg + 50 mg Tablet/Capsule ,J05AR10 
Lopinavir + Ritonavir,Oral:,40 mg + 10 mg Oral pellets contained in capsule ,J05AR10 
Loratadine,Oral:,10 mg Tablet/Film-coated tablet *Primary Health Care,R06AX13
Loratadine,Oral:,5 mg/5 mL Syrup in 30 mL *Primary Health Care,R06AX13
Losartan,Oral:,50 mg (as Potassium) Tablet *Primary Health Care,C09CA01
Losartan,Oral:,100 mg (as Potassium) Tablet *Primary Health Care,C09CA01
Losartan + Hydrochlorothiazide,Oral:,50 mg + 12.5 mg Tablet *Primary Health Care,C09DA01
Lynestrenol,Oral:,500 mcg Tablet ,G03AC02
Magnesium Sulfate,Inj.:,"250 mg/mL (as Heptahydrate) in 2 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
Magnesium Sulfate,Inj.:,"250 mg/mL (as Heptahydrate) in 10 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
Magnesium Sulfate,Inj.:,250 mg/mL (as Heptahydrate) in 10 mL Vial (IV) ,A12CC02 
Magnesium Sulfate,Inj.:,250 mg/mL (as Heptahydrate) in 20 mL Vial (IV) *Primary Health Care,A12CC02 
Magnesium Sulfate,Inj.:,250 mg/mL (as Heptahydrate) in 50 mL Vial (IV) ,A12CC02 
Magnesium Sulfate,Inj.:,"500 mg/mL (as Heptahydrate) in 2 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
Magnesium Sulfate,Inj.:,"500 mg/mL (as Heptahydrate) in 10 mL Ampul (IM, IV) *Primary Health Care",A12CC02 
Mannitol,Inj.:,20% in 250 mL Bottle (IV) ,B05BC01 
Mannitol,Inj.:,20% in 500 mL Bottle (IV) ,B05BC01 
Mebendazole,Oral:,100 mg Tablet /Capsule *Primary Health Care,P02CA01 
Mebendazole,Oral:,500 mg Tablet /Chewable tablet *Primary Health Care,P02CA01 
Mebendazole,Oral:,50 mg/mL Suspension in 10 mL ,P02CA01 
Mebendazole,Oral:,100 mg/mL Suspension in 30 mL ,P02CA01 
Mebendazole,Oral:,100 mg/mL Suspension in 60 mL ,P02CA01 
Mebeverine,Oral:,100 mg (as Hydrochloride) Tablet ,A03AA04 
Mecobalamin,Oral:,500 mcg Tablet ,B03BA05 
Mecobalamin,Inj.:,"500 mcg/mL in 1 mL Ampul (IM, IV) ",B03BA05 
Medroxyprogesterone,Oral:,5 mg (as Acetate) Tablet ,G03AC06 
Medroxyprogesterone,Oral:,10 mg (as Acetate) Tablet ,G03AC06 
Medroxyprogesterone,Inj.:,50 mg/mL (as Acetate) in 3 mL Vial with syringe (IM)(N.B.: Use 1 inch long needle) *Primary Health Care,G03AC06 
Medroxyprogesterone,Inj.:,150 mg/mL (as Enanthate/Acetate) in 1 mL Vial ,G03AC06 
Mefenamic Acid,Oral:,250 mg Tablet /Capsule *Primary Health Care,M01AG01 
Mefenamic Acid,Oral:,500 mg Tablet /Capsule *Primary Health Care,M01AG01 
Mefloquine,Oral:,250 mg (as Hydrochloride) Tablet ,P01BC02 
Megestrol,Oral:,40 mg (as Acetate) Tablet ,L02AB01 
Megestrol,Oral:,160 mg (as Acetate) Tablet ,L02AB01 
Melphalan,Oral:,2 mg Tablet ,L01AA03 
Memantine,Oral:,5 mg Film-coated tablet ,N06DX01
Memantine,Oral:,10 mg Film-coated tablet ,N06DX01
Meningococcal polysaccharide (Neisseria meningitidis) Vaccine,Inj.:,"50 mcg/0.5 mL x 10 doses, Lyophilized powder Multidose vial + 5 mL diluent  (IM, SC)(Group A + C) *Primary Health Care",J07AH02
Meningococcal polysaccharide (Neisseria meningitidis) Vaccine,Inj.:,"50 mcg/0.5 mL Lyophilized powder Single dose vial + 0.5 mL diluent  (IM, SC)(Group A + C) *Primary Health Care",J07AH02
Meningococcal polysaccharide (Neisseria meningitidis) Vaccine,Inj.:,"50 mcg/0.5 mL x 10 doses, Lyophilized powder Multidose vial + Diluent (IM, SC)(Serogroup A + Serogroup B + Serogroup Wl35 + Serogroup Y) *Primary Health Care",J07AH02
Mercaptopurine,Oral:,50 mg Tablet ,L01BB02 
Meropenem *Reserve antimicrobial,Inj.:,500 mg (as Trihydrate) Powder Vial (IV) ,J01DH02
Meropenem *Reserve antimicrobial,Inj.:,1 g (as Trihydrate) Powder Vial (IV) ,J01DH02
Mesalazine,Oral:,500 mg Enteric-coated tablet ,A07EC02 
Mesalazine,Oral:,500 mg Enteric Modified Release (MR) tablet ,A07EC02 
Mesalazine,Rectal:,250 mg Suppository ,A07EC02 
Mesalazine,,Gastro-resistant Prolonged Release (PR) granules in 1.5 g Sachet ,A07EC02 
Mesalazine,Oral:,1 g Prolonged release tablet ,A07EC02 
Mesalazine,Oral:,2 g Prolonged release tablet ,A07EC02 
Mesalazine,Oral:,1 g Suppository ,A07EC02 
Mesna (Sodium-2-mercaptoethanesulphonate),Inj.:,100 mg /mL in 4 mL Ampul (IV) ,V03AF01 
Metformin,Oral:,500 mg (as Hydrochloride) Tablet/Film-coated tablet *Primary Health Care,A10BA02 
Metformin,Oral:,850 mg (as Hydrochloride) Tablet *Primary Health Care,A10BA02 
Methimazole/Thiamazole,Oral:,5 mg Tablet *Primary Health Care,H03BB02 
Methimazole/Thiamazole,Oral:,10 mg Tablet *Primary Health Care,H03BB02 
Methotrexate,Oral:,2.5 mg (as Base/Sodium/Disodium) Tablet ,L01BA01 
Methotrexate,Inj.:,"5 mg/mL (as Sodium) in 3 mL Vial (IM, IV) ",L01BA01 
Methotrexate,Inj.:,"25 mg/mL (as Base) in 2 mL Ampul/Vial (IM, IV, Intrathecal) ",L01BA01 
Methotrexate,Inj.:,"25 mg/mL (as Sodium) in 2 mL Vial (IM, IV, Intrathecal)(Preservative free) ",L01BA01 
Methotrexate,Inj.:,"25 mg/mL (as Sodium) in 20 mL Vial (IM, IV, Intrathecal)(Preservative free) ",L01BA01 
Methotrexate,Inj.:,100 mg/mL (as Base) in 10 mL Vial ,L01BA01 
Methotrexate,Inj.:,"100 mg/mL (as Sodium) in 10 mL Vial (IM, IV, Intrathecal)(Preservative free) ",L01BA01 
Methyldopa,Oral:,250 mg Tablet *Primary Health Care,C02AB01 
Methylene Blue,Oral:,1% Solution ,V04CG05 
Methylene Blue,Inj.:,10 mg/ mL in 1 mL Ampul/Vial ,V04CG05 
Methylene Blue,Inj.:,10 mg/ mL in 10 mL Ampul/Vial ,V04CG05 
Methylergometrine/Methylergonovine,Inj.:,200 mcg/ mL (as Hydrogen maleate/Maleate) in 1 mL Ampul ,G02AB01 
Methylphenidate,Oral:,10 mg Tablet ,N06BA04 
Methylphenidate,Oral:,18 mg Modified Release (MR) tablet ,N06BA04 
Methylphenidate,Oral:,27 mg Modified Release (MR) tablet ,N06BA04 
Methylphenidate,Oral:,36 mg Modified Release (MR) tablet ,N06BA04 
Methylphenidate,Oral:,20 mg Modified Release (MR) capsule ,N06BA04 
Methylprednisolone,Oral:,4mg Tablet *Primary Health Care,H02AB04 
Methylprednisolone,Oral:,16 mg Tablet *Primary Health Care,H02AB04 
Methylprednisolone,Inj.:,"125 mg/mL (as Sodium succinate) Powder in 2 mL Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
Methylprednisolone,Inj.:,"40 mg (as Sodium succinate) Solution for injection Single dose vial (IM, IV) ",H02AB04 
Methylprednisolone,Inj.:,"500 mg (as Sodium succinate) in 7.7 mL Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
Methylprednisolone,Inj.:,"1 g/16 mL (as Sodium succinate) Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
Methylprednisolone,Inj.:,"125 mg (as Sodium succinate) Lyophilized powder Vial (IM, IV) ",H02AB04 
Methylprednisolone,Inj.:,"500 mg (as Sodium succinate) Lyophilized powder Vial (IM, IV) ",H02AB04 
Methylprednisolone,Inj.:,"1 g (as Sodium succinate) Lyophilized powder Vial (IM, IV) ",H02AB04 
Methylprednisolone,Inj.:,"500 mg/8 mL (as Sodium succinate) Powder Vial + Diluent (IM, IV, IV infusion) ",H02AB04 
Metoclopramide,Inj.:,10 mg (as Hydrochloride) Tablet *Primary Health Care,A03FA01 
Metoclopramide,Inj.:,5 mg/5 mL (as Base /Hydrochloride) Syrup in 60 mL *Primary Health Care,A03FA01 
Metoclopramide,Inj.:,"5 mg/mL (as Base /Hydrochloride) in 2 mL Ampul (IM, IV) ",A03FA01 
Metoprolol,Oral:,50 mg (as Tartrate) Tablet *Primary Health Care,C07AB02 
Metoprolol,Oral:,100 mg (as Tartrate) Tablet *Primary Health Care,C07AB02 
Metronidazole,Oral:,250 mg Tablet *Primary Health Care,J01XD01 
Metronidazole,Oral:,500 mg Tablet *Primary Health Care,J01XD01 
Metronidazole,Oral:,125 mg/5 mL (as Base) Suspension in 60 mL *Primary Health Care,J01XD01 
Metronidazole,Oral:,200 mg/5 mL (as Benzoate) Suspension in 60 mL *Primary Health Care,J01XD01 
Metronidazole,Inj.:,5 mg/mL in 100 mL Vial (IV infusion) ,J01XD01 
Micafungin *Reserve antimicrobial,Inj.:,50 mg Lyophilized powder for infusion (IV infusion) ,J02AX05 
Miconazole,Topical:,20 mg Oral gel in 3.5 g Aluminum collapsible tube ,A07AC01 
Miconazole,Topical:,2% (20 mg/g) Cream in 5 g Aluminum collapsible tube ,A07AC01 
Miconazole,Vaginal:,"1.2 g x 1, Suppository Casing strip ",A07AC01 
Micronutrient Powder,,"in 1 g Sachet composed of:
Vitamin A = 400 ug RE
Vitamin C = 30 mg
Vitamin D = 5 ug
Vitamin E = 5 mg a-TE
Vitamin B1 = 0.5 mg
Vitamin B2 = 0.5 mg
Vitamin B6 = 0.5 mg
Vitamin B12 = 0.9 ug
Folic acid = 150 ug
Niacin = 6 mg
Iron = 10 mg
Zinc = 4.1 mg
Copper = 0.56 mg
Iodine = 90 ug S
Elenium = 17 ug *Primary Health Care",A16AB02 
Midazolam,Inj.:,15 mg Tablet ,N05CD08
Midazolam,Inj.:,"1 mg/mL in 5 mL Ampul (IM, IV) ",N05CD08
Midazolam,Inj.:,"5 mg/mL in 1 mL Ampul (IM, IV) ",N05CD08
Midazolam,Inj.:,"5 mg/mL in 2 mL Ampul (IM, IV) ",N05CD08
Midazolam,Inj.:,"5 mg/mL in 3 mL Ampul (IM, IV) ",N05CD08
Midazolam,Inj.:,"5 mg/mL in 5 mL Ampul (IM, IV) ",N05CD08
Midazolam,Inj.:,"5 mg/mL in 10 mL Ampul (IM, IV) ",N05CD08
Mitoxantrone,Inj.:,2mg/ mL Solution in 5 mL ,L01DB07 
Mitoxantrone,Inj.:,2mg/ mL Solution in 10 mL ,L01DB07 
Modified Fluid Gelatin (polymerisate of degraded succinylated gelatin),Inj.:,3% Solution in 500 mL Bottle (IV infusion) ,B05AA06
Modified Fluid Gelatin (polymerisate of degraded succinylated gelatin),Inj.:,4% Solution in 500 mL Bottle (IV infusion) ,B05AA06
Monobasic potassium phosphate + Dibasic potassium phosphate (Potassium Phosphate),Inj.:,"224 mg (equiv. to 3 mmol phosphorus and 4.4 mEq K) + 236 mg (as anhydrous) per mL, in 5 mL Vial (IV) ",B05XA06
Monobasic/Dibasic Sodium Phosphate,Oral:,48g/ 18g  Solution in 45 mL Bottle ,A06AD17 
Monobasic/Dibasic Sodium Phosphate,Rectal:,19g/ 7g Solution in 66 mL Bottle (Enema) ,A06AD17 
Monobasic/Dibasic Sodium Phosphate,Rectal:,19g/ 7g Solution in 133 mL Bottle (Enema) ,A06AD17 
Montelukast,Oral:,4 mg (as Sodium) Granules Sachet *Primary Health Care,R03DC03 
Montelukast,Oral:,4 mg (as Sodium) Chewable tablet *Primary Health Care,R03DC03 
Montelukast,Oral:,5 mg (as Sodium) Chewable tablet *Primary Health Care,R03DC03 
Montelukast,Oral:,10 mg (as Sodium) Tablet *Primary Health Care,R03DC03 
Morphine,Oral:,10 mg (as Sulfate) Tablet/Capsule ,N02AA01 
Morphine,Oral:,20 mg (as Sulfate) Tablet/Capsule ,N02AA01 
Morphine,Oral:,30 mg (as Sulfate) Tablet/Capsule ,N02AA01 
Morphine,Oral:,10 mg (as Sulfate) Modified Release (MR) tablet ,N02AA01 
Morphine,Oral:,30 mg (as Sulfate) Modified Release (MR) tablet ,N02AA01 
Morphine,Oral:,60 mg (as Sulfate) Modified Release (MR) tablet ,N02AA01 
Morphine,Inj.:,"10 mg/mL (as Sulfate) in 1 mL Ampul (IM, IV, SC) ",N02AA01 
Morphine,Inj.:,"16 mg/mL (as Sulfate) in 1 mL Ampul (IM, IV) ",N02AA01 
Moxifloxacin,Oral:,400 mg Film-coated tablet ,J01MA14 
Moxifloxacin,Ophthalmic:,5 mg/mL (0.5% w/v) (as Hydrochloride) Sterile Ophthalmic Solution in 5 mL ,J01MA14 
Multivitamins,Oral:,"per 1 mL, (Infants)(Drops) composed of:
Vitamin A = 325 - 380 mcg
Vitamin B1 = 0.2 - 0.4 mg
Vitamin B2 = 0.3 - 0.4 mg
Vitamin B6 = 0.3 - 0.6 mg
Vitamin B12 = 0.3 - 0.4 mcg
Vitamin C = 30 mg
Vitamin D = 200 - 400 IU (5 - 10 mcg)
Vitamin E = 3 - 4 mg
Folic acid = 20 - 65 mcg
Niacin = 1 - 5 mg *Primary Health Care",A11AB
Multivitamins,Oral:,"per 5 mL, (Children)(Syrup) composed of:
Vitamin A = 350 - 400 mcg
Vitamin B1 = 0.5 - 1.0 mg
Vitamin B2 = 0.7 - 0.9 mg
Vitamin B6 = 0.9 - 1.6 mg
Vitamin B12 = 0.9 - 3.0 mcg
Vitamin C = 35 - 55 mg
Vitamin D = 200 - 400 IU (5 - 10 mcg)
Vitamin E = 5 - 7 mg
Folic acid = 40 - 300 mcg
Niacin = 5 - 18 mg *Primary Health Care",A11AB
Multivitamins,Oral:,"Tablet/Capsule (Adult) composed of:
Vitamin A = 600 - 700 mcg (2000 - 2500 IU)
Vitamin B1 = 1.3 - 1.7 mg
Vitamin B2 = 0.7 - 1.3 mg
Vitamin B6 = 1.6 - 2.0 mg
Vitamin B12 = 2.0 - 6.0 mcg
Vitamin C = 60 - 80 mg
Vitamin D =  400 IU (10 mcg)
Vitamin E = 6 - 10 mg (15 - 30 IU)
Folic acid = 400 mcg
Niacin = 13 - 23 mg *Primary Health Care",A11AB
Mupirocin,Topical:,2% Cream in 5 g Sachet *Primary Health Care,D06AX09 
Mupirocin,Topical:,2% Cream in 15 g Tube *Primary Health Care,D06AX09 
Mupirocin,Topical:,2% Ointment in 5 g Tube *Primary Health Care,D06AX09 
Mupirocin,Topical:,2% Ointment in 15 g Tube *Primary Health Care,D06AX09 
Mycophenolate Acid,Oral:,360 mg (as Mycophenolate Sodium) Tablet ,L04AA06 
Mycophenolate Mofetil,Oral:,500 mg Tablet ,L04AA 
N-acetyl Penicillamine,Oral:,25 g/ bottle Crystal ,V03AB 
Nalbuphine,Inj.:,10 mg/mL (as Hydrochloride) in 1 mL Ampul ,N02AF02
Nalidixic Acid,Oral:,500 mg Tablet ,J01MB02 
Nalidixic Acid,Oral:,250 mg/5 mL Suspension in 60 mL ,J01MB02 
Naloxone,Inj.:,"400 mcg/mL (as Hydrochloride) in 1 mL Ampul (IM, IV, SC) ",A06AH04 
Naltrexone,Oral:,50 mg (as Hydrochloride) Tablet ,N07BB04 
Naproxen,Oral:,250 mg (as Base) Tablet *Primary Health Care,M01AE02 
Naproxen,Oral:,275 mg (as Sodium) Tablet *Primary Health Care,M01AE02 
Naproxen,Oral:,500 mg (as Base) Tablet *Primary Health Care,M01AE02 
Naproxen,Oral:,550 mg (as Sodium) Tablet *Primary Health Care,M01AE02 
Neomycin + Polymixin B + Fluocinolone Acetonide,Otic:,"3.5 mg (as Sulfate) + 10,000 units (as Sulfate) + 0.025% per mL, Otic drop solution in 5 mL *Primary Health Care",D06AX 
Neostigmine,Inj.:,500 mcg/mL in 10 mL Vial ,N07AA01
Neostigmine,Inj.:,"500 mcg/mL Solution for injection in 1 mL Ampul (IM, IV, SC) ",N07AA01
Nepafenac,Ophthalmic:,1 mg/mL Ophthalmic drop suspension in 5 mL ,S01BC10 
Nevirapine,Oral:,200 mg Tablet ,J05AG01 
Nevirapine,Oral:,50 mg Dispersible tablet ,J05AG01 
Nevirapine,Oral:,50 mg/5 mL Suspension in 240 mL ,J05AG01 
Nicardipine,Inj.:,1 mg/mL (as Hydrochloride) in 2 mL Ampul (IV) *Primary Health Care,C08CA04
Nicardipine,Inj.:,1 mg/mL (as Hydrochloride) in 10 mL Ampul (IV) *Primary Health Care,C08CA04
Nicotine,Oral:,1 mg Pastille *Primary Health Care,N07BA01 
Nicotine,Oral:,2 mg Pastille *Primary Health Care,N07BA01 
Nicotine,Oral:,1 mg Gum *Primary Health Care,N07BA01 
Nicotine,Oral:,2 mg Gum *Primary Health Care,N07BA01 
Nicotine transdermal therapeutic system,Patch:,7 mg Patch *Primary Health Care,N07BA01 
Nicotine transdermal therapeutic system,Patch:,14 mg Patch *Primary Health Care,N07BA01 
Nicotine transdermal therapeutic system,Patch:,21 mg Patch *Primary Health Care,N07BA01 
Nifedipine,Oral:,10 mg Capsule (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ,C08CA05 
Nifedipine,Oral:,30 mg Modified Release (MR) tablet ,C08CA05 
Nimodipine,Oral:,30 mg Tablet ,C08CA06 
Nitrofurantoin,Oral:,50 mg Capsule As Macrocrystals *Primary Health Care,J01XE01
Nitrofurantoin,Oral:,100 mg Capsule As Macrocrystals *Primary Health Care,J01XE01
Nitrous Oxide,Inhalation:,Anesthetic gas ,N01AX13 
Norepinephrine,Inj.:,1 mg/mL (as Bitartrate) in 2 mL Ampul (IV infusion) ,C01CA03
Norepinephrine,Inj.:,1 mg/mL (as Bitartrate) in 4 mL Ampul (IV infusion) ,C01CA03
Norepinephrine,Inj.:,1 mg/mL (as Bitartrate) Concentrate solution for IV infusion in 10 mL Ampul (IV infusion) ,C01CA03
Norepinephrine,Inj.:,2 mg/mL (as Bitartrate) Solution for injection in 4 mL Ampul ,C01CA03
Norethisterone,Oral:,5 mg (as Acetate/Base) Tablet ,G03AC01
Nystatin,Oral:,"100,000 units/mL Suspension in 30 mL ",D01AA01 
Nystatin,Vaginal:,"100,000 units Tablet ",D01AA01 
Octreotide,Inj.:,100 mcg/mL (as Acetate) in 1 mL Ampul (IV infusion) ,H01CB02 
Octreotide,Inj.:,500 mcg/mL (as Acetate) in 1 mL Ampul (IV infusion) ,H01CB02 
Ofloxacin,Oral:,200 mg Tablet ,J01MA01 
Ofloxacin,Ophthalmic:,0.3% Ophthalmic drop solution in 5 mL ,J01MA01 
Ofloxacin,Otic:,0.3% Otic drop solution in 5 mL *Primary Health Care,J01MA01 
Olanzapine,Oral:,5 mg Tablet *Primary Health Care,N05AH03 
Olanzapine,Oral:,10 mg Tablet *Primary Health Care,N05AH03 
Olanzapine,Oral:,10 mg Orodispersible tablet (ODT) *Primary Health Care,N05AH03 
Olodaterol,Inhalation:,"2.5 mcg/puff (as Hydrochloride) x 60 puffs (equiv. to 30 medicinal doses), Solution for Inhalation Inhaler with 4 mL cartridge with 60 puffs ",R03AC19 
Omeprazole,Oral:,20 mg Capsule *Primary Health Care,A02BC01 
Omeprazole,Oral:,40 mg Capsule *Primary Health Care,A02BC01 
Omeprazole,Inj.:,40 mg Powder + 10 mL solvent (Ampule/Vial) (IV) ,A02BC01 
Ondansetron,Oral:,8 mg (as Hydrochloridedihydrate) Tablet ,A04AA01 
Ondansetron,Inj.:,"2 mg/mL in 2 mL Ampul (IM, IV) ",A04AA01 
Ondansetron,Inj.:,"2 mg/mL in 4 mL Ampul (IM, IV) ",A04AA01 
Oral Rehydration Salts (ORS 75-replacement),Oral:,"(L of water) composed of:
Sodium chloride = 2.6 g
Trisodium citrate dihydrate = 2.9 g
Potassium chloride = 1.5 g
Glucose anhydrous = 13.5 g
Total weight = 20.5 g
(WHO recommended)(N.B.: Reconstitute with clean potable water) *Primary Health Care",A07CA
Oral Rehydration Salts (ORS 75-replacement),Oral:,"(mmol/L) composed of:
Sodium = 75
Chloride = 65
Potassium = 20
Citrate = 10
Glucose anhydrous = 75
Total osmolarity = 245
(WHO recommended)(N.B.: Reconstitute with clean potable water) *Primary Health Care",A07CA
Oseltamivir,Oral:,75 mg (as Phosphate) Capsule *Primary Health Care,J05AH02
Oxacillin,Inj.:,"250 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CF04 
Oxacillin,Inj.:,"500 mg (as Sodium) Vial (IM, IV) *Primary Health Care",J01CF04 
Oxaliplatin,Inj.:,5 mg/mL Concentrate solution in 10 mL Vial (IV infusion) ,L01XA03
Oxaliplatin,Inj.:,5 mg/mL Concentrate solution in 20 mL Vial (IV infusion) ,L01XA03
Oxaliplatin,Inj.:,50 mg Powder Vial (IV infusion) ,L01XA03
Oxcarbazepine,Oral:,300 mg Tablet ,N03AF02 
Oxcarbazepine,Oral:,600 mg Tablet ,N03AF02 
Oxcarbazepine,Oral:,60 mg/mL Oral suspension in 100 mL ,N03AF02 
Oxcarbazepine,Oral:,60 mg/mL Oral suspension in 250 mL ,N03AF02 
Oxycodone,Oral:,5 mg (as Hydrochloride) Capsule ,N02AA05
Oxycodone,Oral:,10 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
Oxycodone,Oral:,20 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
Oxycodone,Oral:,40 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
Oxycodone,Oral:,80 mg (as Hydrochloride) Tablet/Prolonged Release (PR) tablet/Controlled Release (CR) tablet ,N02AA05
Oxycodone,Inj.:,10 mg/mL (as Hydrochloride) in 1 mL Ampul (IV infusion) ,N02AA05
Oxycodone,Inj.:,10 mg/mL (as Hydrochloride) in 2 mL Ampul (IV infusion) ,N02AA05
Oxycodone + Naloxone,Oral:,5 mg (as Hydrochloride) + 2.5 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
Oxycodone + Naloxone,Oral:,10 mg (as Hydrochloride) + 5 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
Oxycodone + Naloxone,Oral:,20 mg (as Hydrochloride) + 10 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
Oxycodone + Naloxone,Oral:,40 mg (as Hydrochloride) + 20 mg (as Hydrochloride) Prolonged Release (PR) tablet ,N02AA55
Oxygen,Inhalation:,(Medicinal gas) ,V03AN01 
Oxymetazoline,Nasal:,0.025% (as Hydrochloride) Solution in 10 mL Spray ,R01AA05 
Oxymetazoline,Nasal:,0.05% (as Hydrochloride) Solution in 10 mL ,R01AA05 
Oxymetazoline,Nasal:,0.05% (as Hydrochloride) Solution in 15 mL ,R01AA05 
Oxytocin (Synthetic),Inj.:,"10 IU/mL in 1 mL Ampul (IM, IV) *Primary Health Care",H01BB02 
Paclitaxel,Inj.:,"6 mg/mL in 5 mL Vial (IV,IV infusion) ",L01CD01 
Paclitaxel,Inj.:,"6 mg/mL in 16.7 mL Vial (IV,IV infusion) ",L01CD01 
Paclitaxel,Inj.:,"6 mg/mL in 17 mL Vial (IV,IV infusion) ",L01CD01 
Paclitaxel,Inj.:,"6 mg/mL in 25 mL Vial (IV,IV infusion) ",L01CD01 
Paclitaxel,Inj.:,"6 mg/mL in 43.4 mL Vial (IV,IV infusion) ",L01CD01 
Paliperidone,Inj.:,50 mg/0.5 mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
Paliperidone,Inj.:,75 mg/0.75 mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
Paliperidone,Inj.:,100 mg/mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
Paliperidone,Inj.:,150 mg/1.5 mL Polonged Release (PR) suspension for injection (IM) ,N05AX13 
Pancuronium,Inj.:,"2 mg/mL (as Bromide) in 2 mL Ampul (IM, IV) ",M03AC01 
Pantoprazole,Oral:,20 mg Tablet/Enteric coated tablet ,A02BC02 
Pantoprazole,Oral:,40 mg Tablet/Enteric coated tablet ,A02BC02 
Para-amino salicylic acid,Oral:,4 g Enteric coated delayed release (DR) granules Sachet ,J04AA01 
Paracetamol,Oral:,300 mg Tablet *Primary Health Care,N02BE01
Paracetamol,Oral:,500 mg Tablet *Primary Health Care,N02BE01
Paracetamol,Oral:,100 mg/mL Drops in 15 mL (Alcohol-free) *Primary Health Care,N02BE01
Paracetamol,Oral:,120 mg/5 mL (125 mg/5 mL) Syrup/Suspension in 30 mL (Alcohol-free) ,N02BE01
Paracetamol,Oral:,120 mg/5 mL (125 mg/5 mL) Syrup/Suspension in 60 mL (Alcohol-free) *Primary Health Care,N02BE01
Paracetamol,Oral:,120 mg/5 mL (125 mg/5 mL) Syrup/Suspension in 120 mL (Alcohol-free) ,N02BE01
Paracetamol,Oral:,250 mg/5 mL Syrup/Suspension in 30 mL (Alcohol-free) ,N02BE01
Paracetamol,Oral:,250 mg/5 mL Syrup/Suspension in 60 mL (Alcohol-free) *Primary Health Care,N02BE01
Paracetamol,Oral:,250 mg/5 mL Syrup/Suspension in 120 mL (Alcohol-free) ,N02BE01
Paracetamol,Inj.:,"150 mg/mL Solution for injection in 2 mL Ampul (IM, IV) ",N02BE01
Paracetamol,Inj.:,10 mg/mL Solution for infusion in 50 mL Vial (IV infusion) *Primary Health Care,N02BE01
Paracetamol,Inj.:,10 mg/mL Solution for infusion in 100 mL Vial (IV infusion) *Primary Health Care,N02BE01
Paracetamol,Rectal:,125 mg Suppository *Primary Health Care,N02BE01
Paracetamol,Rectal:,250 mg Suppository *Primary Health Care,N02BE01
Peginterferon Alfa 2A,Inj.:,135 mcg/0.5 mL Pre-filled syringe ,L03AB11 
Penicillin G Benzathine/Benzathine benzylpenicillin,Inj.:,"1,200,000 units Vial (IM) *Primary Health Care",J01CE08 
Penicillin G/benzylpenicillin Crystalline,Inj.:,"1,000,000 units (as Sodium) Vial (IM, IV) *Primary Health Care",J01CE01 
Penicillin G/benzylpenicillin Crystalline,Inj.:,"5,000,000 units (as Sodium) Vial (IM, IV) *Primary Health Care",J01CE01 
Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 1.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 1.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 2.3% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 2.3% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 2.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 2.5% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 2 L Bottle/Bag + 4.25% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Peritoneal Dialysis Solution,,"Sterile Solution in 5 L Bottle/Bag + 4.25% Dextrose composed of (per L):
Glucose monohydrate = 16.5 g (equiv. to 15 g glucose)
Fructose = up to 0.75 g
Sodium chloride = 5.786 g
Sodium (S) - lactate solution (equiv. to 3.925 g sodium (S) - lactate) = 7.85 g
Calcium chloride dihydrate = 183.8 mg
Magnesium chloride hexahydrate = 101.7 mg ","B05DA (isotonic)
B05DB (hypertonic)"
Permethrin,Topical:,1% Lotion in 125 mL Bottle *Primary Health Care,P03AC04 
Permethrin,Topical:,5% Shampoo in 30 mL Bottle (Crème rinse) *Primary Health Care,P03AC04 
Permethrin,Topical:,5% Shampoo in 60 mL Bottle (Crème rinse) *Primary Health Care,P03AC04 
Permethrin,Topical:,1% Lotion in 30 mL Bottle *Primary Health Care,P03AC04 
Permethrin,Topical:,1% Lotion in 60 mL Bottle *Primary Health Care,P03AC04 
Pethidine/Meperidine,Inj.:,"50 mg/mL (as Hydrochloride) in 2 mL Ampul (IM, IV, SC) ",N02AB02 
Petrolatum/Petroleum,Topical:,Jelly in 25 g Jar USP Grade ,D02AX
Petrolatum/Petroleum,Topical:,Jelly in 100 g Jar USP Grade ,D02AX
Petrolatum/Petroleum,Topical:,Jelly in 200 g Jar USP Grade ,D02AX
Phenobarbital,Oral:,15 mg Tablet ,N03AA02 
Phenobarbital,Oral:,30 mg Tablet ,N03AA02 
Phenobarbital,Oral:,60 mg Tablet ,N03AA02 
Phenobarbital,Oral:,90 mg Tablet ,N03AA02 
Phenobarbital,Inj.:,"120 mg/mL in 1 mL Ampul (IM, IV) ",N03AA02 
Phenobarbital,Inj.:,"130 mg/mL (as Sodium) in 1 mL Ampul (IM, IV) ",N03AA02 
Phenoxymethyl Penicillin/Penicillin V,Oral:,250 mg (as Potassium) Tablet/Capsule *Primary Health Care,J01CE02 
Phenoxymethyl Penicillin/Penicillin V,Oral:,500 mg (as Potassium) Tablet/Capsule *Primary Health Care,J01CE02 
Phenoxymethyl Penicillin/Penicillin V,Oral:,250 mg/5 mL (as Potassium) Granules/powder for syrup/suspension in 60 mL *Primary Health Care,J01CE02 
Phenylephrine,Ophthalmic:,2.5% (as Hydrochloride) Ophthalmic drop solution in 5 mL ,R01AB01 
Phenytoin,Oral:,100 mg (as Sodium) Tablet ,N03AB02 
Phenytoin,Oral:,30 mg/5 mL (as Sodium) Suspension in 120 mL ,N03AB02 
Phenytoin,Oral:,125 mg/5 mL (as Sodium) Suspension in 120 mL ,N03AB02 
Phenytoin,Inj.:,50 mg/ mL (as Sodium) in 2 mL Ampul (IV) ,N03AB02 
Phenytoin,Inj.:,50 mg/ mL (as Sodium) in 5 mL Ampul (IV) ,N03AB02 
Phospholipid fraction from bovine lung,Inj.:,45 mg/mL (54 mg/1.2 mL) Lyophilized powder for suspension (Intratracheal administration) ,R07AA02 
Physostigmine,Inj.:,"1 mg/mL (as Salicylate) in 2 mL Ampul (IM, IV) ",V03AB19 
Phytomenadione/Phytonadione/Vitamin K1,Oral/Inj.:,"2 mg/0.2 mL Ampul (IM, IV, PO)(Pediatric)(As mixed micelle) *Primary Health Care",B02BA01
Phytomenadione/Phytonadione/Vitamin K1,Inj.:,"10 mg/mL in 1 mL Ampul (IM, IV, SC)(As aqueous colloidal solution with benzyl alcohol) *Primary Health Care",B02BA01
Phytomenadione/Phytonadione/Vitamin K1,Inj.:,"10 mg/mL in 1 mL Ampul (IM, IV, SC)(As mixed micelle) *Primary Health Care",B02BA01
Pilocarpine,Ophthalmic:,1% (as Hydrochloride) Ophthalmic drop solution in 10 mL ,S01EB01 
Pilocarpine,Ophthalmic:,1% (as Hydrochloride) Ophthalmic drop solution in 15 mL ,S01EB01 
Pilocarpine,Ophthalmic:,2% (as Hydrochloride) Ophthalmic drop solution in 10 mL ,S01EB01 
Pilocarpine,Ophthalmic:,2% (as Hydrochloride) Ophthalmic drop solution in 15 mL ,S01EB01 
Piperacillin + Tazobactam,Inj.:,2 g + 250 mg (as Sodium) Vial (IV infusion) ,J01CR05
Piperacillin + Tazobactam,Inj.:,4 g + 500 mg (as Sodium) Vial (IV infusion) ,J01CR05
Pneumococcal Conjugate Vaccine,Inj.:,10-valent (2 mL) Suspension for IM injection in 3 mL Multidose vial (IM) ,J07AL02 
Pneumococcal Conjugate Vaccine,Inj.:,"13-valent 0.5 mL single dose, Suspension for IM injection in 0.5 mL Pre-filled syringe (IM) ",J07AL02 
Pneumococcal Conjugate Vaccine,Inj.:,13-valent Suspension for IM injection in 2 mL Multidose vial (IM) ,J07AL02 
Pneumococcal Polyvalent Vaccine,Inj.:,"25 mcg/0.5 mL Solution for injection in 0.5 mL Pre-filled syringe/Single dose vial (IM, SC)(Polysaccharide from each capsular type) ",J07AL01 
Pneumococcal Polyvalent Vaccine,Inj.:,"25 mcg/0.5 mL Solution for injection in 2.5 mL Multidose vial (IM, SC) ",J07AL01 
Polymyxin B *Reserve antimicrobial,Inj.:,"500,000 IU (as Sulfate) Powder for solution for injection in 5 mL Vial (Intrathecal, IM, IV) ",A07AA05 
Poractant alfa,Inj.:,80 mg/mL Sterile Suspension in 1.5 mL Vial (Intratracheal/Intrabronchial) ,R07AA 
Poractant alfa,Inj.:,80 mg/mL Sterile Suspension in 3 mL Vial (Intratracheal/Intrabronchial) ,R07AA 
Potassium,Oral:,10 mEq (as Citrate) Tablet ,A12BA
Potassium,Oral:,1620 mg (15 mEq) Tablet ,A12BA
Potassium Chloride,Oral:,600 mg Tablet *Primary Health Care,A12BA01 
Potassium Chloride,Oral:,750 mg (equiv. to approximately 10 mEq potassium) Durules *Primary Health Care,A12BA01 
Potassium Chloride,Inj.:,1 mmol/mL (as Chloride) Syrup in 30 mL *Primary Health Care,A12BA01 
Potassium Chloride,Inj.:,1 mmol/mL (as Chloride) Syrup in 60 mL *Primary Health Care,A12BA01 
Potassium Chloride,Inj.:,2 mEq/mL in 2 mL Ampul (IV infusion) ,A12BA01 
Potassium Chloride,Inj.:,2 mEq/mL in 5 mL Ampul (IV infusion) ,A12BA01 
Potassium Chloride,Inj.:,2 mEq/mL in 10 mL Vial (IV infusion) ,A12BA01 
Potassium Chloride,Inj.:,2 mEq/mL in 20 mL Vial (IV infusion) ,A12BA01 
Povidone iodine,Oral antiseptic:,1% in 60 mL Bottle *Primary Health Care,D08AG02 
Povidone iodine,Oral antiseptic:,1% in 120 mL Bottle *Primary Health Care,D08AG02 
Povidone iodine,Oral antiseptic:,1% in 240 mL Bottle ,D08AG02 
Povidone iodine,Topical:,10% Ointment in 5 g Tube *Primary Health Care,D08AG02 
Povidone iodine,Topical:,10% Ointment in 15 g Tube *Primary Health Care,D08AG02 
Povidone iodine,Topical:,10% Ointment in 30 g Tube ,D08AG02 
Povidone iodine,Topical:,10% Paint in 10 mL Bottle *Primary Health Care,D08AG02 
Povidone iodine,Topical:,10% Solution in 15 mL Bottle ,D08AG02 
Povidone iodine,Topical:,10% Solution in 30 mL Bottle ,D08AG02 
Povidone iodine,Topical:,10% Solution in 60 mL Bottle *Primary Health Care,D08AG02 
Povidone iodine,Topical:,10% Solution in 120 mL Bottle *Primary Health Care,D08AG02 
Povidone iodine,Topical:,10% Solution in 1 L Bottle ,D08AG02 
Povidone iodine,Topical:,10% Solution in 1 Gallon Bottle ,D08AG02 
Povidone iodine,Topical:,7.5% in 60 mL Bottle (Surgical skin cleanser) *Primary Health Care,D08AG02 
Povidone iodine,Topical:,7.5% in 120 mL Bottle (Surgical skin cleanser) *Primary Health Care,D08AG02 
Povidone iodine,Topical:,7.5% in 480 mL Bottle (Surgical skin cleanser) ,D08AG02 
Povidone iodine,Topical:,7.5% in 1 L Bottle (Surgical skin cleanser) ,D08AG02 
Povidone iodine,Topical:,7.5% in 1 Gallon Bottle (Surgical skin cleanser) ,D08AG02 
Pralidoxime Chloride,Inj.:,50 mg/mL in 20 mL Vial (IV) ,V03AB04 
Praziquantel,Oral:,600 mg Tablet (Available under DOH program) *Primary Health Care,P02BA01 
Prednisolone,Oral:,15 mg/5 mL (as Sodium phosphate) Syrup in 60 mL ,H02AB06 
Prednisolone,Ophthalmic:,0.5% (as Acetate) Ophthalmic drop suspension in 5 mL ,H02AB06 
Prednisolone,Ophthalmic:,1% (as Acetate) Ophthalmic drop suspension in 5 mL ,H02AB06 
Prednisone,Oral:,5 mg Tablet *Primary Health Care,H02AB07 
Prednisone,Oral:,10 mg Tablet *Primary Health Care,H02AB07 
Prednisone,Oral:,20 mg Tablet *Primary Health Care,H02AB07 
Prednisone,Oral:,10 mg/5 mL Suspension in 60 mL *Primary Health Care,H02AB07 
Primaquine,Oral:,26.3 mg (15 mg base) Tablet *Primary Health Care,P01BA03 
Propofol,Inj.:,10 mg/mL in 20 mL Ampul (IV) ,N01AX10
Propofol,Inj.:,10 mg/mL in 50 mL Pre-filled syringe (IV) ,N01AX10
Propofol,Inj.:,10 mg/mL in 20 mL Vial (IV) ,N01AX10
Propofol,Inj.:,10 mg/mL in 50 mL Vial (IV) ,N01AX10
Propranolol,Oral:,10 mg (as Hydrochloride) Tablet ,C07AA05 
Propranolol,Oral:,40 mg (as Hydrochloride) Tablet ,C07AA05 
Propylthiouracyl,Oral:,50 mg Tablet ,H03BA02 
Protamine Sulfate,Inj.:,10 mg/mL in 5 mL Ampul (IV) ,V03AB14 
Protamine Sulfate,Inj.:,10 mg/mL in 25 mL Ampul (IV) ,V03AB14 
Prothionamide,Oral:,250 mg Film-coated tablet ,J04AD01 
Proxymetacaine/Proparacaine,Ophthalmic:,0.5% (as Hydrochloride) Ophthalmic drop solution in 5 mL ,S01HA04 
Proxymetacaine/Proparacaine,Ophthalmic:,0.5% (as Hydrochloride) Ophthalmic drop solution in 15 mL ,S01HA04 
Pyrazinamide,Oral:,500 mg Tablet *Primary Health Care,J04AK01 
Pyrazinamide,Oral:,250 mg/5 mL Suspension in 120 mL *Primary Health Care,J04AK01 
Pyrazinamide,Oral:,500 mg/5 mL Suspension in 120 mL *Primary Health Care,J04AK01 
Pyridostigmine,Oral:,60 mg (as Bromide) Tablet ,N07AA02 
Pyridoxine/Vitamin B6,Oral:,100 mg (as Hydrochloride) Tablet ,A11HA02
Pyrimethamine,Oral:,25 mg Tablet ,P01BD01 
Pyrimethamine,Oral:,75 mg Tablet ,P01BD01 
Quetiapine,Oral:,25 mg (as Fumarate) Tablet ,N05AH04 
Quetiapine,Oral:,100 mg (as Fumarate) Tablet ,N05AH04 
Quetiapine,Oral:,200 mg (as Fumarate) Tablet ,N05AH04 
Quetiapine,Oral:,300 mg (as Fumarate) Tablet ,N05AH04 
Quinine,Oral:,325 mg Tablet ,P01BC01 
Quinine,Inj.:,300 mg (as Sulfate) Tablet ,P01BC01 
Quinine,Inj.:,300 mg/mL (as Dihydrochloride) in 1 mL Ampul (IV) ,P01BC01 
Quinine,Inj.:,250 mg/mL (as Dihydrochloride) in 1 mL Ampul (IV) ,P01BC01 
Rabeprazole ,Oral:,10 mg (as Sodium) Tablet ,A02BC04
Rabeprazole ,Oral:,20 mg (as Sodium) Tablet ,A02BC04
"Rabies (Chick Embryo - purified, inactivated) Vaccine",Inj.:,"2.5 IU/mL Lyophilized powder in 1 Dose vial + 1 mL diluent (ID, IM) *Primary Health Care",J07BG01 
Rabies (Vero Cell - purified) Vaccine,Inj.:,"2.5 IU/mL Lyophilized powder in 0.5 mL Vial + Diluent (ID, IM) *Primary Health Care",J07BG01 
Rabies (Vero Cell - purified) Vaccine,Inj.:,2.5 IU/mL Suspension in 1 mL Vial (IM) *Primary Health Care,J07BG01 
Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 2 mL Vial (IM) *Primary Health Care,J06BB05 
Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 5 mL Vial (IM) *Primary Health Care,J06BB05 
Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 2 mL Ampul (IM) *Primary Health Care,J06BB05 
Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 5 mL Ampul (IM) *Primary Health Care,J06BB05 
Rabies Immunoglobulin (Human),Inj.:,150 IU/mL in 10 mL Ampul (IM) *Primary Health Care,J06BB05 
Ranitidine,Oral:,150 mg (as Hydrochloride) Tablet ,A02BA02 
Ranitidine,Oral:,300 mg (as Hydrochloride) Tablet ,A02BA02 
Ranitidine,Oral:,75 mg/5 mL (as Hydrochloride) Syrup in 60 mL ,A02BA02 
Ranitidine,Oral:,75 mg/5 mL (as Hydrochloride) Syrup in 150 mL ,A02BA02 
Ranitidine,Inj.:,"25 mg/mL (as Hydrochloride) in 2 mL Ampul/Vial (IM, IV, IV infusion) ",A02BA02 
Regular Insulin (Recombinant DNA human),Inj.:,"100 IU/mL in 3 mL Pre-filled syringe (IM, IV, SC) *Primary Health Care",A10AC01 
Regular Insulin (Recombinant DNA human),Inj.:,"100 IU/mL in 5 mL Vial (IM, IV, SC) *Primary Health Care",A10AC01 
Regular Insulin (Recombinant DNA human),Inj.:,"100 IU/mL in 10 mL Vial (IM, IV, SC) *Primary Health Care",A10AC01 
Remdesivir,IV:,100 mg Lyophilized powder ,J05AB16
Remifentanil,Inj.:,1 mg Lyophilized powder Vial (IV infusion) ,N01AH06 
Remifentanil,Inj.:,2 mg Lyophilized powder Vial (IV infusion) ,N01AH06 
Retinol/Vitamin A,Oral:,"10,000 IU (as Palmitate) Soft gel capsule *Primary Health Care",A11CA01
Retinol/Vitamin A,Oral:,"25,000 IU (as Palmitate) Soft gel capsule *Primary Health Care",A11CA01
Retinol/Vitamin A,Oral:,"50,000 IU (as Palmitate) Soft gel capsule *Primary Health Care",A11CA01
Retinol/Vitamin A,Oral:,"100,000 IU (as Palmitate) Soft gel capsule with nipple (Only for DOH program) *Primary Health Care",A11CA01
Retinol/Vitamin A,Oral:,"200,000 IU (as Palmitate) Soft gel capsule with nipple (Only for DOH program) *Primary Health Care",A11CA01
Ribavirin,Oral:,200 mg Tablet ,J05AP01 
Ribavirin,Oral:,500 mg Tablet ,J05AP01 
Ribavirin,Oral:,600 mg Tablet ,J05AP01 
Rifabutin,Oral:,"150 mg Capsule (For HIV/AIDS patient on concomitant protease inhibitor therapy, in lieu of rifampicin) ",J04AB04 
Rifampicin,Oral:,300 mg Tablet/Capsule *Primary Health Care,J04AB02 
Rifampicin,Oral:,450 mg Tablet/Capsule *Primary Health Care,J04AB02 
Rifampicin,Oral:,600 mg Tablet/Capsule *Primary Health Care,J04AB02 
Rifampicin,Oral:,200 mg/5 mL Suspension in 120 mL *Primary Health Care,J04AB02 
Rifapentine,Oral:,150 mg Film-coated tablet ,J04AB05 
Rifaximin,Oral:,200 mg Tablet ,A07AA11 
Rilpivirine,Oral:,25 mg (as Hydrochloride) Tablet ,J05AG05 
Risperidone,Oral:,1 mg Tablet *Primary Health Care,N05AX08 
Risperidone,Oral:,2 mg Tablet *Primary Health Care,N05AX08 
Risperidone,Oral:,3 mg Tablet *Primary Health Care,N05AX08 
Risperidone,Oral:,4 mg Tablet *Primary Health Care,N05AX08 
Risperidone,Oral:,1 mg Orodispersible tablet (ODT) *Primary Health Care,N05AX08 
Risperidone,Oral:,2 mg Orodispersible tablet (ODT) *Primary Health Care,N05AX08 
Risperidone,Oral:,1 mg/mL Oral Solution in 100 mL *Primary Health Care,N05AX08 
Risperidone,Inj.:,25 mg Modified Release (MR) Powder for suspension Vial + 2 mL diluent in pre-filled syringe (IM) *Primary Health Care,N05AX08 
Risperidone,Inj.:,37.5 mg Modified Release (MR) Powder for suspension Vial + 2 mL diluent in pre-filled syringe (IM) *Primary Health Care,N05AX08 
Risperidone,Inj.:,50 mg Polonged Release (PR) suspension for injection + 2 mL diluent (IM)(This should not be administered to patients with dementia-related psychoses because of high risk of cardiovascular and infectiious related deaths.) ,N05AX08 
Rituximab,Inj.:,10 mg/mL in 10 mL Vial (IV) ,L01FA01 
Rituximab,Inj.:,10 mg/mL in 50 mL Vial (IV) ,L01FA01 
Rivaroxaban,Oral:,15 mg Film-coated tablet ,B01AF01 
Rivaroxaban,Oral:,20 mg Film-coated tablet ,B01AF01 
Rivastigmine,Oral:,1.5 mg (as Hydrogen tartrate) Capsule ,N06DA03 
Rivastigmine,Oral:,3 mg (as Hydrogen tartrate) Capsule ,N06DA03 
Rivastigmine,Oral:,6 mg (as Hydrogen tartrate) Capsule ,N06DA03 
Rocuronium,Inj.:,10 mg/mL (as Bromide) in 5 mL Ampul/Vial (IV) ,M03AC09 
Ropivacaine,Inj.:,10 mg/mL (as Hydrochloride) in 10 mL Ampul (IV) ,N01BB09 
Rosuvastatin,Oral:,10 mg (as Calcium) Tablet *Primary Health Care,C10AA07 
Rosuvastatin,Oral:,20 mg (as Calcium) Tablet *Primary Health Care,C10AA07 
Rotavirus Vaccine,Oral:,"1.5 mL Suspension in Pre-filled glass syringe 

Contains:
Monovalent G1P[8] strain, Live, attenuated, containing NLT 10^6.0 cell culture infectious dose ",J07BH01
Rotavirus Vaccine,Oral:,"1.5 mL Suspension in 3 mL ready-to-use plastic tube (sterile polyethylene squeezable tube with nozzle fitted with a tip seal and a tube cap (polypropylene)) 

Contains:
Monovalent G1P[8] strain, Live, attenuated, containing NLT 10^6.0 cell culture infectious dose ",J07BH01
Rotavirus Vaccine,Oral:,"2 mL Solution in 2 mL single dose ready-to-use plastic tube (single dose plastic dosing tube in individual foil pouch per box) 

Contains:
Pentavalent G1, G2, G3, G4, and P1A[8] strains, live, attenuated, containing live reassortant rotaviruses - G1, G2, G3, G4 and P1A[8] with a minimum of 2.0-2.8 x 10^6 infectious units (IU) per reassortant dose ",J07BH01
Sacubitril + Valsartan,Oral:,24.3 mg + 25.7 mg Tablet (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ,C09DX04 
Sacubitril + Valsartan,Oral:,"48.6 ,g + 51.4 mg Tablet (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ",C09DX04 
Sacubitril + Valsartan,Oral:,97.2 mg + 102.8 mg Tablet (Restricted use for acute hypertensive emergencies in patients less than 18 years old with extreme caution due to rapid and prolonged fall in blood pressure) ,C09DX04 
Salbutamol,Oral:,2 mg/5 mL (as Sulfate) Syrup in 60 mL *Primary Health Care,R03AC02 
Salbutamol,Inhalation:,200 mcg/dose (as Sulfate) DPI with appropriate accompanying dispenser ,R03AC02 
Salbutamol,Inhalation:,"100 mcg/dose (as Sulfate) x 200 actuations, MDI *Primary Health Care",R03AC02 
Salbutamol,Inhalation:,"100 mcg/dose (as Sulfate) x 200 actuations, Breath actuated MDI *Primary Health Care",R03AC02 
Salbutamol,Inhalation:,1 mg/mL (as Sulfate) Respiratory solution in 2.5 mL Unit dose (For nebulization) *Primary Health Care,R03AC02 
Salbutamol,Inhalation:,2 mg/mL (as Sulfate) Respiratory solution in 2.5 mL Unit dose (For nebulization) *Primary Health Care,R03AC02 
Salicylic Acid,Topical:,5% Solution in 30 mL ,D01AE12 
Salicylic Acid,Topical:,5% Solution in 60 mL ,D01AE12 
Sambong (Blumea balsamifera),Oral:,250 mg Tablet (Fam. Compositae) ,Not Available
Sambong (Blumea balsamifera),Oral:,500 mg Tablet (Fam. Compositae) ,Not Available
Selegiline,Oral:,5 mg (as Hydrochloride) Tablet ,N04BD01 
Selenium,Topical:,2.5% (as Sulfide) Lotion in 100 mL ,D01AE13 
Sertraline,Oral:,50 mg (as Hydrochloride) Tablet *Primary Health Care,N06AB06 
Sevelamer,Oral:,800 mg (as Carbonate) Tablet ,V03AE02 
Sevelamer,Oral:,800 mg (as Carbonate) Powder for suspension ,V03AE02 
Sevoflurane,Inhalation:,in 250 mL Bottle ,N01AB08
Silver Sulfadiazine,Topical:,1% Cream in 15 g Tube *Primary Health Care,D06BA01 
Silver Sulfadiazine,Topical:,1% Cream in 25 g Tube *Primary Health Care,D06BA01 
Silver Sulfadiazine,Topical:,Cream in 500 g Jar (Micronized) *Primary Health Care,D06BA01 
Simvastatin,Oral:,20 mg Tablet *Primary Health Care,C10AA01 
Simvastatin,Oral:,40 mg Tablet *Primary Health Care,C10AA01 
Sirolimus,Oral:,0.5 mg Tablet ,S01XA23
Sirolimus,Oral:,1 mg Tablet ,S01XA23
Sodium ,Inj.:,0.9% (as Chloride) in 2 mL Ampul (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 2.5 mL Ampul (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 5 mL Ampul (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 10 mL Ampul (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 20 mL Ampul (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 50 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 100 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 200 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 500 mL Bottle/Bag (IV infusion) *Primary Health Care,A12CA
Sodium ,Inj.:,0.9% (as Chloride) in 1 L Bottle/Bag (IV infusion) *Primary Health Care,A12CA
Sodium ,,"0.9% (as Chloride) in 1 L Bottle/Bag (For irrigation)Composed of:
Na+ = 154 mmol/L
Cl- = 154 mmol/L ",A12CA
Sodium Bicarbonate,Oral:,325 mg Tablet ,B05CB04 
Sodium Bicarbonate,Oral:,650 mg Tablet ,B05CB04 
Sodium Bicarbonate,Inj.:,1 mEq/mL in 10 mL Vial (Pediatric) ,B05CB04 
Sodium Bicarbonate,Inj.:,1 mEq/mL in 20 mL Ampul/Vial (Adult)(IV infusion) ,B05CB04 
Sodium Bicarbonate,Inj.:,1 mEq/mL in 50 mL Ampul/Vial (Adult)(IV infusion) ,B05CB04 
Sodium Bicarbonate,Inj.:,1 mEq/mL in 100 mL Ampul/Vial (Adult)(IV infusion) ,B05CB04 
Sodium bicarbonate + Acid concentrates (Hemodialysis Solution),Inj.:,"650 g + Acid Concentrates (g/L) composed of:
Glucose = 0-49.5 g
Sodium chloride = 216.19-270.8 g
Potassium chloride = 5.25-6.7 g
Calcium chloride = 6.46-9.9 g
Magnesium chloride = 3.58-4.75 g
Glacial acetic acid = 8.1-8.46 g
Purified water = 1000 mL ",B05ZA
Sodium bicarbonate + Glutamic acid + Tartaric acid + Silicon resin (Gas Forming Agent),Oral:,470 mg + 70 mg + 420 mg + 25 mg Tablet ,Not available
Sodium Calcium Edetate,Inj.:,200 mg/mL in 5 mL Ampul (IM) ,V03AB03
Sodium Chloride,Inj.:,2.5 mEq/mL in 20 mL Vial *Primary Health Care,B05XA03 
Sodium Chloride,Inj.:,2.5 mEq/mL in 50 mL Vial *Primary Health Care,B05XA03 
Sodium Dichloroisocyanurate,,3.5 mg Tablet (2 mg free chlorine)(To be used for water purification) ,D08AX 
Sodium Dichloroisocyanurate,,8.68 mg Tablet (5 mg free chlorine)(To be used for water purification) ,D08AX 
Sodium Dichloroisocyanurate,,12.5 mg Tablet (8 mg free chlorine)(To be used for water purification) ,D08AX 
Sodium Dichloroisocyanurate,,17 mg Tablet (10 mg free chlorine)(To be used for water purification) ,D08AX 
Sodium Dichloroisocyanurate,,67 mg Tablet (40 mg free chlorine)(To be used for water purification) ,D08AX 
Sodium Hyaluronate,Ophthalmic:,0.1% (1 mg/mL) Ophthalmic drop solution in 5 mL ,S01KA 
Sodium Hyaluronate,Ophthalmic:,0.1% (1 mg/mL) Ophthalmic drop solution in 15 mL ,S01KA 
Sodium Hypochlorite,,Solution (1.25% available chlorine for water purification) ,D08AX07
Sodium Iodide,Oral:,Capsule (Radioactivity range of 0.8 - 100 mCi per capsule) ,V09FX03 
Sodium Iodide,Oral:,Capsule (Radioactivity range of 1.0 - 250 mCi per capsule) ,V09FX03 
Sodium Iodide,Oral:,Solution (Radioactivity range of 3.5 - 150 mCi per vial) ,V09FX03 
Sodium Nitrite,Inj.:,Powder (USP Grade) ,V03AB08 
Sodium Nitroprusside,Inj.:,50 mg Powder (IV infusion) ,C02DD01 
Sodium Sulfate,,Powder (USP Grade) ,A06AD13 
Sodium Thiosulfate,Inj.:,250 mg/mL in 50 mL Ampul (IV) ,V03AB 
Sodium Thiosulfate,,2.5% Solution ,V03AB 
Sodium Thiosulfate,,5% Solution ,V03AB 
Sodium Valproate,Oral:,200 mg/5 mL Syrup in 100 mL Bottle *Primary Health Care,N03AG01 
Sodium Valproate + Valproic Acid,Oral:,333 mg + 145 mg Controlled Release (CR) tablet *Primary Health Care,N03AG01 
Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,250 mg Tablet *Primary Health Care,N03AG01
Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,500 mg Tablet *Primary Health Care,N03AG01
Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,250 mg Extended Release (ER) tablet *Primary Health Care,N03AG01
Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,500 mg Extended Release (ER) tablet *Primary Health Care,N03AG01
Sodium Valproate + Valproic Acid (Divalproex Sodium),Oral:,500 mg (333 mg Sodium valproate + 145 mg Valproic acid) Controlled Release (CR) tablet *Primary Health Care,N03AG01
Sofosbuvir,Oral:,400 mg Tablet ,J05AP08 
Sofosbuvir + Ledipasvir,Oral:,400 mg + 90 mg Tablet ,J05AP51 
Sofosbuvir + Velpatasvir,Oral:,400 mg + 100 mg Tablet ,J05AP55 
Somatostatin,Inj.:,"250 mcg Ampul/Vial (IV,IV infusion) ",H01CB01 
Somatostatin,Inj.:,"3 mg Ampul/Vial (IV,IV infusion) ",H01CB01 
Soya bean oil + Medium chain triglycerides + Olive oil + Purified fish oil,Inj.:,20% (200 mg/mL) Emulsion for IV infusion in 250 mL ,B05BA02 
Spectinomycin,Inj.:,2 g Vial (IM) ,J01XX04 
Spironolactone,Oral:,25 mg Tablet (K-sparer) ,C03DA01 
Spironolactone,Oral:,50 mg Tablet (K-sparer) ,C03DA01 
Spironolactone,Oral:,100 mg Tablet (K-sparer) ,C03DA01 
Standard Senna Concentrate,Oral:,187 mg Tablet ,A06AB06 
Standard Senna Concentrate,Oral:,374 mg Tablet ,A06AB06 
Sterile Water for Injection,Inj.:,in 2 mL Ampul (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 5 mL Ampul (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 10 mL Ampul (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 20 mL Ampul (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 50 mL Bottle/Bag (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 100 mL Bottle/Bag (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 500 mL Bottle/Bag (No preservative) *Primary Health Care,V07AB 
Sterile Water for Injection,Inj.:,in 1 L Bottle/Bag (No preservative) *Primary Health Care,V07AB 
Streptokinase,Inj.:,"1,500,000 IU Powder Vial (IV infusion) ",B01AD01 
Streptomycin,Inj.:,1 g (as Sulfate) Vial (IM) ,J01GA01 
Succimer/Dimercapto succinic acid (DMSA),Oral:,100 mg Capsule ,V09CA02 
Succimer/Dimercapto succinic acid (DMSA),Oral:,200 mg Capsule ,V09CA02 
Sucralfate,Oral:,1 g Tablet ,A02BX02 
Sugammadex,Inj.:,100 mg/mL Solution for injection in 2 mL Vial (IV) ,V03AB35 
Sulfacetamide + Prednisolone,Ophthalmic:,10% + 0.25% (as Acetate) Ophthalmic drop suspension in 5 mL ,S01CA02 
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,400 mg + 80 mg Tablet *Primary Health Care,J01EE01
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,400 mg + 80 mg Capsule *Primary Health Care,J01EE01
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,800 mg (as Sulfate) + 160 mg Tablet *Primary Health Care,J01EE01
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,200 mg + 40 mg/5 mL Suspension in 70 mL *Primary Health Care,J01EE01
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,200 mg + 40 mg/5 mL Suspension in 120 mL *Primary Health Care,J01EE01
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Oral:,400 mg + 80 mg/5 mL Suspension in 60 mL *Primary Health Care,J01EE01
Sulfamethoxazole + Trimethoprim (Cotrimoxazole),Inj.:,400 mg + 80 mg in 5 mL Ampul (IV infusion) ,J01EE01
Sulfur,Topical:,2% Cream in 10 g Plastic tube ,D10AB02
Sulfur,Topical:,10% Ointment in 15 g Aluminum collapsible tube ,D10AB02
Sulfur,Topical:,10% Ointment in 30 g Aluminum collapsible tube ,D10AB02
Sumatriptan,Oral:,50 mg Tablet ,N02CC01 
Suxamethonium/Succinylcholine,Inj.:,20 mg/mL (as Chloride) in 10 mL Vial (IV) ,M03AB01 
Tacrolimus,Oral:,1 mg Capsule ,L04AD02 
Tacrolimus,Oral:,5 mg Capsule ,L04AD02 
Tacrolimus,Oral:,1 mg Slow release capsule ,L04AD02 
Tacrolimus,Oral:,5 mg Slow release capsule ,L04AD02 
Tafluprost,Ophthalmic:,15 mcg/mL Ophthalmic drop solution in 0.3 mL Single Dose Bottle ,S01EE05 
Tamoxifen,Oral:,10 mg (as Citrate) Tablet ,L02BA01 
Tamoxifen,Oral:,20 mg (as Citrate) Tablet ,L02BA01 
Tamsulosin,Oral:,200 mcg (as Hydrochloride) Capsule *Primary Health Care,G04CA02 
Tamsulosin,Oral:,200 mcg Orally disintegrating tablet (ODT) ,G04CA02 
Tamsulosin,Oral:,400 mcg Prolonged release film coated tablet ,G04CA02 
Tegafur + Uracil,Oral:,100 mg + 224 mg Capsule ,L01BC53 
Telmisartan,Oral:,40 mg Tablet ,C09CA07 
Telmisartan,Oral:,80 mg Tablet ,C09CA07 
Telmisartan + Hydrochlorothiazide,Oral:,40 mg + 12.5 mg Tablet ,C09DA07 
Tenofovir + Lamivudine + Dolutegravir,Oral:,300 mg + 300 mg + 50 mg Tablet (Fixed-dose combination) ,J05AR27 
Tenofovir alafenamide,Oral:,25 mg (as Fumarate) Tablet ,J05AF13 
Tenofovir disoproxil,Oral:,300 mg (as Fumarate) Tablet ,J05AF07 
Terazosin,Oral:,1 mg (as Hydrochloride) Tablet ,G04CA03 
Terazosin,Oral:,2 mg (as Hydrochloride) Tablet ,G04CA03 
Terazosin,Oral:,5 mg (as Hydrochloride) Tablet ,G04CA03 
Terbinafine,Oral:,250 mg (as Hydrochloride) Tablet ,D01BA02 
Terbinafine,Topical:,1% (as Hydrochloride) Cream in 3 g Tube ,D01BA02 
Terbinafine,Topical:,1% (as Hydrochloride) Cream in 5 g Tube ,D01BA02 
Terbinafine,Topical:,1% (as Hydrochloride) Cream in 10 g Tube ,D01BA02 
Terbinafine,Topical:,1% (as Hydrochloride) Cream in 15 g Tube ,D01BA02 
Terbutaline,Oral:,5 mg (as Sulfate) Tablet ,R03CC03 
Terbutaline,Oral:,1.5 mg/5 mL (as Sulfate) Syrup in 60 mL ,R03CC03 
Terbutaline,Inj.:,"500 mcg/mL (as Sulfate) in 1 mL Ampul (IM,IV,SC) ",R03CC03 
Terbutaline,Inhalation:,2.5 mg/mL (as Sulfate) in 2 mL Unit dose (For nebulization) ,R03CC03 
Testosterone,Inj.:,250 mg/mL (as Undecanoate) Solution for injection in 4 mL ,G03BA03 
Tetanus Immunoglobulin (Human),Inj.:,1000 IU/mL in 1.5 mL Vial (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,1500 IU/mL in 1 mL Ampul (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 1 mL Ampul (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 2 mL Ampul (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 4 mL Ampul (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 1 mL Pre-filled syringe (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 1 mL Vial (IM) *Primary Health Care,J06BB02 
Tetanus Immunoglobulin (Human),Inj.:,250 IU/mL in 2 mL Vial (IM) *Primary Health Care,J06BB02 
Tetanus Toxoid,Inj.:,in 0.5 mL Ampul (IM) *Primary Health Care,J07AM01 
Tetanus Toxoid,Inj.:,in 10 mL Vial (IM) *Primary Health Care,J07AM01 
Tetracaine,Inj.:,20 mg (as Hydrochloride) Sterile powder Ampul (Spinal) ,S01HA03 
Tetracycline,Oral:,250 mg Capsule ,J01AA07 
Tetracycline,Oral:,500 mg Capsule ,J01AA07 
Theophylline (Anhydrous),Oral:,150 mg Tablet ,R03DA04 
Theophylline (Anhydrous),Oral:,200 mg Tablet ,R03DA04 
Theophylline (Anhydrous),Oral:,200 mg Modified Release (MR) tablet ,R03DA04 
Theophylline (Anhydrous),Oral:,25 mg/5 mL (26.7 mg/5 mL) Syrup in 100 mL ,R03DA04 
Thiamine/Vitamin B1,Oral:,100 mg (as Hydrochloride) Tablet ,A11DA01 
Thiamine/Vitamin B1,Oral:,300 mg (as Hydrochloride) Tablet ,A11DA01 
Thiamine/Vitamin B1,Inj.:,100 mg/mL (as Hydrochloride) in 1 mL Ampul/Vial (IV) ,A11DA01 
Thiamine/Vitamin B1,Inj.:,"100 mg/mL (as Hydrochloride) in 10 mL Vial (IM,IV) ",A11DA01 
Thiopental Sodium,Inj.:,500 mg Vial (IV) ,N01AF03 
Thiopental Sodium,Inj.:,1 g Vial + 50 mL diluent (IV) ,N01AF03 
Timolol,Ophthalmic:,0.5% (as Maleate) Ophthalmic drop solution in 5 mL ,C07AA06 
Tinzaparin,Inj.:,"10,000 anti-Xa IU/mL (as Sodium) in 0.35 mL Pre-filled syringe (SC) ",B01AB10 
Tinzaparin,Inj.:,"10,000 anti-Xa IU/mL (as Sodium) in 0.45 mL Pre-filled syringe (SC) ",B01AB10 
Tinzaparin,Inj.:,"10,000 anti-Xa IU/mL (as Sodium) in 2 mL Vial (SC) ",B01AB10 
Tiotropium,Inhalation:,18 mcg/dose  (as Bromide) DPI with appropriate accompanying dispenser ,R03BB04 
Tobramycin,Ophthalmic:,0.3% Ophthalmic drop solution in 5 mL Bottle *Primary Health Care,S01AA12 
Tobramycin,Ophthalmic:,0.3% Ophthalmic ointment in 3.5 g  Tube *Primary Health Care,S01AA12 
Tobramycin + Dexamethasone,Ophthalmic:,0.3% + 0.1% Ophthalmic drop suspension in 5 mL Bottle *Primary Health Care,S01CA01 
Tobramycin + Dexamethasone,Ophthalmic:,0.3% + 0.1% Ophthalmic ointment in 3.5 g  Tube *Primary Health Care,S01CA01 
Tocilizumab,Inj.:,80 mg/4 mL (20 mg/mL) Concentrate for solution for IV infusion ,L04AC07 
Tocilizumab,Inj.:,200 mg/10 mL (20 mg/mL) Concentrate for solution for IV infusion ,L04AC07 
Tocilizumab,Inj.:,400 mg/20 mL (20 mg/mL) Concentrate for solution for IV infusion ,L04AC07 
Tolvaptan,Oral:,15 mg Tablet ,C03XA01 
Topiramate,Oral:,25 mg Tablet ,N03AX11
Topiramate,,50 mg Tablet ,N03AX11
Topiramate,Oral:,100 mg Tablet ,N03AX11
Trace Elements,Oral:,"Ampule Composed of:
Zn, Cu, Mn, Mg, Mb, etc.,
(IV nutrition) ",A11AA04 
Tramadol,Oral:,50 mg (as Hydrochloride) Capsule *Primary Health Care,N02AX02 
Tramadol,Oral:,50 mg (as Hydrochloride) Dispersible tablet ,N02AX02 
Tramadol,Oral:,100 mg (as Hydrochloride) Modified Release (MR) tablet ,N02AX02 
Tramadol,Oral:,150 mg (as Hydrochloride) Modified Release (MR) tablet ,N02AX02 
Tramadol,Oral:,200 mg (as Hydrochloride) Modified Release (MR) tablet ,N02AX02 
Tramadol,Inj.:,"50 mg/mL (as Hydrochloride) in 1 mL Ampul (IM, IV, SC) ",N02AX02 
Tramadol,Inj.:,"50 mg/mL (as Hydrochloride) in 2 mL Ampul (IM, IV, SC) ",N02AX02 
Tranexamic Acid,Oral:,250 mg Capsule *Primary Health Care,B02AA02 
Tranexamic Acid,Oral:,500 mg Capsule *Primary Health Care,B02AA02 
Tranexamic Acid,Oral:,500 mg Tablet ,B02AA02 
Tranexamic Acid,Inj.:,"100 mg/mL in 2.5 mL Ampule (IM,IV) ",B02AA02 
Tranexamic Acid,Inj.:,"100 mg/mL in 5 mL Ampule (IM,IV) ",B02AA02 
Trastuzumab,Inj.:,150 mg Lyophilized powder (IV infusion) ,L01FD01 
Trastuzumab,Inj.:,600 mg/5 mL (120 mg/Ml) Solution for injection in 5 mL Vial (SC) ,L01FD01 
Travoprost,Ophthalmic:,0.004% Ophthalmic drop solution in 2.5 mL ,S01EE04 
Triclabendazole,Oral:,250 mg Tablet ,P02BX04 
Trimetazidine,Oral:,35 mg (as Hydrochloride) Tablet ,C01EB15 
Tropicamide,Ophthalmic:,0.5% Ophthalmic drop solution in 5 mL ,S01FA06 
Tropicamide + Phenylephrine hydrochloride,Ophthalmic:,5 mg + 5 mg/mL Ophthalmic drop solution in 10 mL (Fixed-dose combination) ,S01FA56 
Tsaang Gubat [Carmona retusa (Vahl) Masam] ,Oral:,250 mg Tablet (Fam. Boraglinaceae) ,Not available
"Tuberculin , Purified Protein Derivative (PPD)",Inj.:,2 TU/0.1 mL Solution in 1 mL Vial (ID) ,V04CF01 
"Tuberculin , Purified Protein Derivative (PPD)",Inj.:,2 TU/0.1 mL Solution in 5 mL Vial (ID) ,V04CF01 
"Tuberculin , Purified Protein Derivative (PPD)",Inj.:,5 TU/0.1 mL Freeze-dried powder Vial + 2 mL diluent ampul (ID) ,V04CF01 
Typhoid Vaccine,Oral:,Enteric-coated tablet (encapsulated) Live attenuated S. typhi (not less than 109) viable strain *Primary Health Care,J07AP01 
Typhoid Vaccine,Inj.:,"25 mcg Pre-filled syringe Vi-capsular polysaccharide S. typhi
(IM) *Primary Health Care",J07AP01 
Ursodeoxycholic Acid,Oral:,250 mg Capsule ,A05AA02
Ursodeoxycholic Acid,Oral:,250 mg Tablet ,A05AA02
Ursodeoxycholic Acid,Oral:,500 mg Tablet ,A05AA02
Valaciclovir,Oral:,500 mg (as Hydrochloride) Tablet ,J05AB11 
Valganciclovir,Oral:,450 mg Tablet ,J05AB14 
Valproic Acid,Oral:,250 mg/5 mL Syrup in 120 mL *Primary Health Care,N03AG01 
Valproic Acid,Inj.:,500 mg/5 mL in 5 mL Vial (IV infusion) ,N03AG01 
Valsartan,Oral:,80 mg Tablet/Film-coated tablet ,C09CA03 
Valsartan,Oral:,160 mg Tablet/Film-coated tablet ,C09CA03 
Valsartan + Hydrochlorothiazide,Oral:,80 mg + 12.5 mg Tablet ,C09DX01 
Vancomycin *Reserve antimicrobial,Inj.:,500 mg (as Hydrochloride) Vial (IV) ,J01XA01 
Vancomycin *Reserve antimicrobial,Inj.:,1 g (as Hydrochloride) Vial (IV) ,J01XA01 
Varenicline,Oral:,0.5 mg Tablet *Primary Health Care,S01XA28 
Varenicline,Oral:,1 mg Tablet *Primary Health Care,S01XA28 
Varicella Zoster Immunoglobulin (VZIG),Inj.:,125 units/1.25 mL Vial (IM) ,J06BB03 
Vasopressin,Inj.:,"20 IU/mL (IM,IV) ",H01BA01 
Vecuronium,Inj.:,4 mg/mL (as Bromide) Freeze-dried powder Ampul + 1 mL solvent (IV) ,M03AC03 
Verapamil,Oral:,80 mg (as Hydrochloride) Tablet ,C08DA01 
Verapamil,Oral:,240 mg (as Hydrochloride) Modified Release (MR) tablet (For maintenance therapy) ,C08DA01 
Verapamil,Inj.:,2.5 mg/mL (as Hydrochloride) in 2 mL Ampul (IV) ,C08DA01 
Vinblastine,Inj.:,"10 mg (as Sulfate) Powder Vial (IV)(For reconstitution)
 ",L01CA01 
Vinblastine,Inj.:,1 mg/mL (as Sulfate) in 10 mL Vial (IV) ,L01CA01 
Vincristine,Inj.:,1 mg/mL (as Sulfate) in 1 mL Vial (IV) ,L01CA02 
Vincristine,Inj.:,1 mg/mL (as Sulfate) in 2 mL Vial (IV) ,L01CA02 
Vitamin B1  + B6 + B12,Oral:,100 mg + 5 mg + 50 mcg Tablet/Capsule *Primary Health Care,A11DB
Vitamin B1  + B6 + B12,Oral:,"10 mg + 5 mg + 5 mcg per 0.6 mL drops, Drops ",A11DB
Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per 3 mL, Ampule (IV) ",A11DB
Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per 10 mL, Vial (IV) ",A11DB
Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per mL, in 3 mL Ampul (IV) ",A11DB
Vitamin B1  + B6 + B12,Inj.:,"100 mg + 100 mg + 1 mg per mL, in 10 mL Vial (IV) ",A11DB
"Vitamin Intravenous, Fat-soluble",Inj.:,"in 10 mL Ampul (IV) contains Vitamins A, D, E, and K ",B05XC
"Vitamin Intravenous, Water-soluble",Inj.:,"Contains vitamin B complex and vitamin C, 1 mL vial
and 2 mL ampule",B05XC
Voriconazole *Reserve antimicrobial,Oral:,200 mg Film-coated tablet ,J02AC03
Voriconazole *Reserve antimicrobial,Inj.:,200 mg Lyophilized  powder for solution for IV infusion in 30 mL Vial ,J02AC03
Warfarin,Oral:,"1 mg (as Sodium) Tablet Ampul Composed of:
Vitamins A, D, E, K ",B01AA03 
Warfarin,Oral:,1 mg (as Sodium) Tablet ,B01AA03 
Warfarin,Oral:,2.5 mg (as Sodium) Tablet ,B01AA03 
Warfarin,Oral:,5 mg (as Sodium) Tablet ,B01AA03 
Yellow Fever Vaccine,Inj.:,"1000 DL 50 mouse min (Attenuated) Vial + 0.5 mL solvent syringe (IM, SC)(For Bureau of Quarantine use only) ",J07BL01 
Zidovudine,Oral:,100 mg Capsule ,J05AF01 
Zidovudine,Oral:,300 mg Tablet ,J05AF01 
Zidovudine,Oral:,50 mg/5 mL Suspension in 240 mL Bottle ,J05AF01 
Zidovudine + Lamivudine,Oral:,60 mg + 30 mg Dispersible tablet ,J05AR01 
Zinc,Oral:,(equiv. to 10 mg elemental zinc) (as Gluconate) Chewable tablet *Primary Health Care,A12CB 
Zinc,Oral:,(equiv. to 30 mg elemental zinc) (as Gluconate trihydrate) Tablet ,A12CB 
Zinc,Oral:,88 mg (equiv. to 20 mg zinc) (as Sulfate) Dispersible tablet ,A12CB 
Zinc,Oral:,(equiv. to 10 mg elemental zinc per mL) (as Sulfate monohydrate) Drops in 15 mL *Primary Health Care,A12CB 
Zinc,Oral:,(equiv. to 20 mg elemental zinc per 5 mL) (as Sulfate monohydrate) Syrup in 60 mL *Primary Health Care,A12CB 
Zinc,Oral:,70 mg/5 mL (equiv. to 10 mg elemental zinc) (as Gluconate) Syrup in 60 mL *Primary Health Care,A12CB 
Zinc,Oral:,70 mg/5 mL (equiv. to 10 mg elemental zinc) (as Gluconate) Syrup in 120 mL *Primary Health Care,A12CB 
Zoledronic Acid,IV:,4 mg/5 mL Concentrated solution for IV infusion ,M05BA08 
Zolmitriptan,Oral:,2.5 mg Tablet ,N02CC03 
Zolpidem,Oral:,10 mg Tablet ,N05CF02 
